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1 Introduction 
 Immune system 1.1
The immune system endows the individual with a self-defence system that is 
essential for protection against the harms of pathogens. Functionally, to this end 
the immune system carries out two related tasks – recognition and response 
and can be qualitatively divided into two components – non-specific and 
specific. The non-specific component is known as innate immunity whereas the 
component with high degree of specificity as well as the remarkable property of 
memory is known as adaptive immunity. Innate immunity plays an important role 
in the first line of immune defence and involves the recognition of a broad range 
of so called PAMPs (pathogen associated molecular pattern) that are common 
to many pathogens. On the other hand, the adaptive immunity develops newly 
in every individual during maturation and involves so called B and T cells as 
major components. These two cell types belong to lymphocyte subset and are 
capable of recognizing different pathogens with highly specific receptors, display 
memory function and carry out humoral (antibody mediated) and cell mediated 
immune responses, respectively. Since B cells are the subject of the present 
work, in the following, these cells and their functions will be described in more 
detail.  
 B lymphocytes 1.2
B cells develop in the fetal liver or the bone marrow. During this phase they 
acquire unique antigen-binding receptors, that can bind to its nominal antigen 
very specifically. These receptors are known as B cell receptor (BCR) and are 
essentially membrane bound antibodies. Upon binding of the specific antigen to 
a BCR in conjunction with other stimuli, B cells differentiate into effector B cells. 
These effector B cells can be divided into two subsets: plasma cells that are 
antibody secreting cells, and memory B cells, that can be activated upon 
secondary encounter with the specific antigen, for example in case of secondary 
infection. Antibodies produced by plasma cells in secretory form constitute the 
major effector component of humoral immunity. 
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 Structure of antibodies 1.2.1
B cells mainly function via their BCR that recognize a specific antigen. The 
soluble and secretory form of this protein is called immunoglobulin (Ig) or 
antibody (Ab) when the specificity is known. It is a tetrameric glycoprotein that 
consists of two heavy (H chain) and two light chains (L chain). These chains are 
linked via disulfide bonds and both heavy chains and both light chains are 
identical in one tetramer. The scheme of an IgG Ab is shown in Figure 1.1. 
 
 
Figure 1.1 Schematic representation of an IgG molecule domain structure 
An antibody is composed of two heavy and two light chains. Depending upon the heavy 
chain constant region, the antibody molecule can belong to one of the five isotypes – 
IgA, IgD, IgE, IgG and IgM. Each antibody contains either λ or κ light chain isotype. The 
hinge region provides steric flexibility and is found in IgD, IgG and IgA isotypes, 
whereas IgM and IgE isotypes contain an additional CH domain. Figure adopted from 
(Düber, 2004). 
 
The chains in an antibody molecule are composed of a variable (V) and a 
constant (C) region. While the variable region of the two chains forms the 
antigen binding site that varies between each antibody molecule on different 
cells, the constant region is conserved in each of the five existing 
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CDRs with HV3 (CDR3) being the most variable one. The regions between the HV regions, 
which comprise the rest of the V part show less variability and are termed the framework (FR) 
regions. There are four such regions in each V part designated FR1, FR2, FR3 and FR4. The 
FR regions form the  sheets that function as the structural backbone of the variable region 
whereas the CDR sequences correspond to three loops at the outer edge of the  barrel, which 
are juxtaposed in the folded domain. When the VH and VL domains are paired in the antibody 
molecule, the CDR loops from each chain are brought together to create the antigen (Ag)-
binding site. These six CDR loops determine Ag specificity by forming a surface 
complementary to the Ag. 
Antibodies are the secreted form of the B cell receptor. They differ in a small portion of the 
carboxy terminus of the heavy chain region from the anchored form. In the case of B cell 
receptor the carboxy terminus is a hydrophobic membrane anchoring sequence, whereas it is a 
hydrophilic sequence in case of secreted antibodies. 
 
 
 
 
 
Figure 1. Schematic representation of an IgG molecule omain stru ture. An antibody is composed of two 
heavy and two light ch i s. Depending upo  the heavy chain const t regi , the antibody molecul  can belong 
to one of the five isotypes Q IgM, D, IgG, IgE and IgA. Each antibody contains eit er  or  light chain 
isotype. The hinge region provides steric flexibility and is found in IgD, IgG, and IgA isotypes, whereas IgM and 
IgE isotypes contain an additional CH d main. (Figure adopted from Düber, 2004). 
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immunoglobulin subsets (IgA, IgD, IgE, IgG and IgM). This constant part of the 
immunoglobulin is responsible for the effector function of the molecule. 
Enormous variability in the V region of antibody molecules are responsible for 
the high diversity in the antibody repertoire. On the basis of the amino acid 
sequence, each V region contains three highly variable stretches on each chain 
(see Figure 1.1). These stretches are called complementarity-determining 
region (CDR1-3) or hypervariable regions. Among these three CDRs the CDR3 
is the most variable. The four regions flanking the CDRs are called framework 
regions (FR1-4), are less diverse and responsible to maintain the structure of 
the variable region. By pairing of the V regions of a heavy and a light chain (VH 
and VL) the CDRs are brought together to form the antigen (Ag)-binding site 
thus generating a complex that is complementary to its Ag. Generation of a 
diverse repertoire of such molecules takes place during the B cell development 
and maturation.  
 How to distinguish B cell subsets? 1.2.2
B cells, as other cells from the immune system can be differentiated into various 
subsets upon their different pattern of surface markers. Very common markers 
for the differentiation of those cells are the cluster of differentiation (CD) 
molecules. Each cell subset as well as each ontogenic state are characterized 
by a specific combination of these markers. In addition, the expression of 
intracellular molecules changes during differentiation and maturation as well. In 
Figure 1.2 the different markers during B cell development are shown. Besides 
their expression of surface markers, mature B cells can be furthermore divided 
into different subsets by function and anatomical location (see chapter 1.2.5). 
 B cell development 1.2.3
During embryonic stage, pluripotent hematopoietic stem cells (PHSCs) found in 
the fetal liver can give rise to B cells. Later on during the neonatal and adult 
stages, precursor B cells are generated from common lymphoid progenitors 
(CLPs) that originate from PHSCs (Hardy and Hayakawa, 2001) (Akingbemi et 
al., 2001)in the bone marrow. The development of B cells is controlled by 
interactions between these cells and the surrounding cytokine milieu produced 
by stromal cells (Vosshenrich et al., 2003; Vosshenrich et al., 2004) .It is tightly 
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regulated at different check-points. If the cell fails to overcome a check-point, it 
undergoes apoptosis. 
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Figure 1.2 Expression of B cell specific markers during its development. 
H: heavy chain; L: light chain; N.R.: not rearranged; +: expression; -: no expression; 
protein: detectable only at protein level; Iµ: germline transcripts of the heavy chain 
locus; SL: surrogate light chain; Cyto-µ: cytoplasmic µ chain; κ0: germline transcripts of 
κ light chain. Adapted from (Engel, 1999) 
 
The earliest committed B cell precursors are known as proB cells that can be 
identified by the expression of B220 and the lack of CD19 (Ogawa et al., 2000) 
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that is expressed from later stage - preB-I stage - onwards as the main B cell 
marker (see Figure 1.2). In addition, AA4.1 is also a very common marker to 
distinguish progenitor B cells from other subsets in the bone marrow as it is 
expressed throughout the whole process of maturation and is lost on mature B 
cells (Hardy and Hayakawa, 2001).  
The pre B cell stage can be separated into two main populations, containing 
dividing cells (large preB-II) and small resting preB cells (small preB-II; (Hardy et 
al., 1991; Tung et al., 2006)). In preB-I cells, the heavy chain of the BCR is 
rearranged. If this pairs effectively with the surrogate light chain it can be 
transported to the cell surface and is presented as pre-BCR. Non-matching 
heavy chains lead to either further rearrangement or to apoptosis of this cell. 
During small preB cells stage, the light chain of the BCR is arranged and by 
fitting this to the heavy chain the cell can further differentiate into the immature 
state in which they become independent of stromal factors in the BM 
(Wasserman et al., 1998).B cells migrate out of the BM at the immature stage 
and further mature in the spleen. All stages can be distinguished from each 
other by surface molecules as shown in Figure 1.2. 
 Heavy chain rearrangement 1.2.4
During the maturation of B cells, the B cell receptor (BCR) is generated in a well 
regulated manner. First, gene segments of the heavy chain are rearranged. to 
form the variable region (V) of the heavy chain. It is composed of different gene 
segments that need to be combined by somatic DNA recombination. The V 
region of the heavy chain contains a variable domain (VH), a joining domain (JH) 
and a diversity domain (DH) that is located between V and J.  
The three gene segments of the heavy chain variable region span a length of 
1.5 mega bases (Mb) and heavy chain (IgH) itself is further extended to 3 Mb by 
the genes encoding the constant part of the BCR (Chowdhury and Sen, 2004).  
The light chain does not contain any D, thus containing only VL and JL. Two 
different light chains exist in mice – κ and λ. They are functionally identical and 
only differ in their order of expression during ontogeny of a B cell (Roy, 2007). It 
10  Introduction 
is that only one of these light chains can be used and presented on the surface 
at a complete BCR. 
On DNA level, the VH are located most distant from the constant domain 
compared to the other segments. In mice, the VH locus can be divided into 15 
gene families containing more than 100 VH gene segments (Chevillard et al., 
2002; Chowdhury and Sen, 2004). Recombination of different genes to form a 
heavy chain is divided into two steps. In the first step, one of 13 DH gene 
segments and one of four JH gene segments are recombined during preB-I 
stage. In the second step, one of the VH genes is rearranged to the DJH for 
completion of the VH region exon (see Figure 1.3). 
 
 
Figure 1.3 Organization of IgH locus  
Location and order of IgH gene segments has been depicted. Black rectangles 
represent several VH genes, the 5’-most (DFL 16.1) and the 3’-most DH gene 
segments have been depicted by pink rectangles. Green and maroon rectangles 
represent the JH and constant chains respectively. Numbers in the parenthesis show 
the number of members belonging to the respective gene family. Three known cis-
regulatory elements, the intronic enhancer Eµ, the Dq52 promoter, and the 3’ locus 
control region are depicted as red ovals (Chowdhury and Sen, 2004). 
 
This recombination process is tightly regulated and requires the expression of 
the recombination activating proteins RAG-1 and RAG-2 (Mombaerts et al., 
1992; Shinkai et al., 1992). Due to a process called allelic exclusion most B cells 
express only a single heavy chain on their surface, although all cells contain two 
heavy chain alleles (Loffert et al., 1996; Melchers et al., 1999). One of the 
checkpoints of B cell development is the assembly of the generated heavy chain 
to a surrogate light chain (SLC) that consists of the proteins λ5 and VpreB. This 
whole complex is called pre-BCR. As soon as a proper heavy chain is able to 
bind to the SLC and can be presented at the cell surface together with other co-
closest to the VH locus, DFL16.1, is located approximately
98 kb, 30 of VH81X. Eleven other DH gene segments are dis-
tributed over 60 kb, which end with Dq52. Interestingly,
Dq52 is separated from the next upstream DH gene segment,
DSp2.10, by an 18 kb gap beyond which the other DH genes
are relatively regularly placed. 30 of Dq52, there is less than a
kilobase to the first of four JH gene segments. The exons
encoding Cm and Cd are located in the next 12 kb, after
which there is a 50-kb gap to the g3 constant region exons.
Coding regi ns for the remaining five isoty es are found in
the next 50 kb. The entire locus encompassing the VH genes
and extending to Ca is approximately 3Mb. This review
focuses on the regulation of IgH gene recombination in the
mouse.
B cells develop in the adult from bone marrow-derived
hematopoietic stem cells (HSCs). Pioneering work of Weissman
and colleagues (4, 5) has led to a model where the HSCs give
rise to two major progenitor populations, the common
myeloid precursors (CMPs) and the common lymphoid pre-
cursors (CLPs), which is the source of B and T lymphocytes,
natural killer cells, and dendritic cells. These early intermedi-
ates retain developmental flexibility, as indicated by the ability
of a strong cytokine signal to redirect CLPs into the myeloid
differentiation pathway (6). Furthermore, many genes of the
‘wrong’ lineage are expressed in both CLPs and CMPs suggest-
ing that they are not irreversibly committed to a differentiation
program (7). Kincade and colleagues have identified an early
lymphocyte precursor (ELP) population in the bone marrow
that reconstitutes both lymphoid lineages (8, 9). ELPs may be
precursors to CLPs, because they do not express the interleu-
kin-7 receptor a chain (IL-7Ra). Moreover, early T-cell pre-
cursors (ETPs), which are not derived from the CLPs, have
been isolated from the blood (10). These observations are
consistent with the idea that ELPs are the precursors for both
CLPs and ETPs, with CLPs being more restricted to B-lineage
differentiation. B-cell differentiation beyond the CLPs has been
staged by the expression of cell-surface markers, as indicated
in Fig. 2 (11).
Regulation of DH-to-JH recombination
The conceptual framework for regulation of antigen receptor
gene rearrangements is provided by the accessibility model of
Alt and colleagues (12,13). Originally proposed to account for
the observation that Ig and T-cell receptor (TCR) genes
contained identical recombination signal sequences (RSSs)
and were therefore targeted by the same enzymatic machinery,
the model proposes that the recombinase only acts on acces-
sible genes. Thus, B-cell antigen receptor (BCR) genes are
targets only in B-cell precursors, while TCR genes are targets
only in T cells. Taken a step further, the accessibility model
postulates that IgH genes are accessible earlier and light-chain
genes are accessible later in the course of B-cell differentiation.
Lineage-specificity and developmental timing of antigen
receptor gene rearrangements have now been shown to be
determined by gene-specific regulatory sequences, identified
Fig. 1. Immunoglobulin h avy-chain (IgH) locus organization. A
schematic representation of the murine IgH with approximate distances
between the gene segments is shown on the top line (98). Several VH
genes, the 50-most DH gene segment (DFL16.1) and 30-most (Dq52) DH
gene segments are indicated along with the different constant region
isotypes. Numbers of each gene family, VH, DH, or JH, are written in
parentheses below the line. Three known cis-regulatory elements, the
intronic enhancer Em, the Dq52 promoter, and the 30 locus control region
(LCR) are depicted as red ovals. The second line is a detailed schematic of
the VH locus showing the relative locations of the gene segments
belonging to J558, 3609, Q52, and 7183 families. This part of the figure
is adapted from Chevillard et al. (1). Black circle represents the telomere.
Chowdhury & Sen ! IgH gene regulation
Immunological Reviews 200/2004 183
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receptors - Igα and Igβ (Reth et al., 2000), the cell proliferates and continues 
differentiation (Geier and Schlissel, 2006).  
In the absence of a proper pre-BCR the RAG-expression is not switched off and 
the recombination of genes proceeds (Grawunder et al., 1995). Further 
development of the B cell is transiently stopped. This mechanism is one of the 
control mechanisms that screens for an appropriate heavy chain being able to 
bind to a light chain later on in development.  
The rearrangement process results in a broad repertoire of different heavy 
chains and in high diversity that is called combinatorial diversity as it is due to 
the random selection of members of the gene segment family for recombination. 
Another reason for the highly diverse repertoire is the consequence of junctional 
diversity. This is due to the addition or deletion of nucleotides at the junctions 
between the different gene segments during the recombination process. While 
the so-called P-nucleotides are added during fetal and adult phase, so called N-
nucleotides are only added in adult BM precursors and are not or very rarely 
found in case of B cells that develop during the fetal stage (Li et al., 1993). 
It is known that in fetal liver, first the proximal VH genes and later during 
rearrangement the distal VH genes are used (Wasserman et al., 1998). It could 
be shown that pre-BCR complexes isolated from BM cells leads to proliferation, 
whereas the same pre-BCR induces the exit of the cycle in fetal liver. There is 
also some evidence, that the proximal VH genes are used first by progenitors in 
the adult BM (Malynn et al., 1990; ten Boekel et al., 1997) but for one study this 
was only shown by isolating pools of BM cells from young mice (Malynn et al., 
1990) so that there is still a risk of contamination of recirculating B cells. The 
other study only analysed a very low number of sequences (ten Boekel et al., 
1997). 
The analysis of acetylation of different VH genes during rearrangement revealed 
that there are differently regulated subdomains. The most distal VH domains are 
responding on IL-7, the genes lying in the middle can be activated by v-abl and 
the most proximal genes were found in an acetylated state as soon as the DJH 
recombination occurred (Chowdhury and Sen, 2001). It was proposed, that this 
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is also a hint for the usage of proximal V genes during early developmental 
stages of B cells in adult BM. 
 B cell maturation 1.2.5
Immature B cells express elevated levels of surface IgM, therefore this is a 
marker for immature B cells (Xing et al., 2009). After differentiation, these 
immature B cells migrate out of the BM and via the blood stream into peripheral 
sites like spleen or peritoneal cavity. In the periphery, the immature or 
transitional (T) B cells can be negatively selected against self-antigens. This 
represents another checkpoint for B cell maturation and can lead to apoptosis.  
It was shown that in the periphery three different types of transitional B cell 
subsets (T1-3) could be defined by their expression of surface IgM, CD23 and 
AA4.1 (Allman et al., 2001). This led to the suggestion that also in periphery a 
stepwise B cell maturation might be taking place (Allman et al., 2001; Allman 
and Pillai, 2008; Loder et al., 1999). Interestingly, Teague and colleagues could 
show that the T3 B cells do not give rise to mature B cells, but rather 
differentiate away from the mature B cell subsets (Teague et al., 2007).  
The mature B cells in the periphery can again be assigned to three different 
main subsets: B-1, B-2 or follicular (FO) and marginal zone (MZ) B cells. The 
classification can be determined according to their characteristics as size, cell 
surface phenotype, functional activity and anatomical location (Allman and Pillai, 
2008; Martin and Kearney, 2001; Pillai et al., 2004).  
B-2 cells are the key players in humoral immune defence during adoptive 
immune reaction. Their antibody repertoire is highly diverse as the BCR besides 
combinatorial and junctional diversity is undergoing somatic hypermutation 
(SHM) upon recognition of an antigen to develop higher affinity (affinity 
maturation). This mutational process is driven by a special enzyme - AID 
(activation induced cytidin desaminase) - which leads to single nucleotide 
replacements (see chapter 1.2.7). Upon appropriate selection, SHM leads to a 
further increase of antibody repertoire as the rearrangement process in the 
maturing precursor B cells already leads to. B cells originating from the B-2 
subset show a defined pattern of surface markers (CD19+B220hiIgMloIgDhiCD43-
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CD21intCD23hi) and require T cell help for their differentiation into effector B cell. 
This indicates that they can be activated to become antibody-secreting cells or 
memory B cells just in a T-dependent manner. 
In contrast, MZ and B-1 B cells can be activated without T cell help. However, 
their antibody repertoire is more restricted as the repertoire of B-2 cells. MZ B 
cells can be mainly found in the marginal zone of the spleen and can be 
characterized by their expression patter as CD19+B220hiIgMhiIgDloCD43-
CD21hiCD23lo/- cells. These cells can be activated by blood borne pathogens 
(Martin et al., 2001) and can thereupon differentiate into short-lived plasma cells 
(Amezcua Vesely et al., 2012). Furthermore, they were thought to be non-
migrating, they rather act as shuttle for transportation of antigens as immune 
complexes from the marginal zone to B-2 cells in the B cell follicles of the spleen 
(Cinamon et al., 2008; Tse et al., 2012).  
The other B cell subset, B-1 cells, can be characterized as 
CD19hiB220loIgMhiIgDloCD43+CD23lo/- expressing cells. In the peritoneal cavity, 
one of their primary locations, most B-1 cells also express CD11b or Mac-1. 
Furthermore, this population can be subdivided due to their expression of CD5 
into B-1a (CD5+) and B-1b (CD5-) cells (Martin and Kearney, 2001). While B-1a 
cells are crucial for the first line of defence and are defined as innate-like B 
cells, B-1b cells are thought to be involved in the adaptive immune response 
and can provide long-lasting T cell-independent IgM memory (Alugupalli et al., 
2004). Both B-1 cell populations can be activated in a T cell independent 
manner and B-1a cells are the major source of natural IgM (for more details see 
chapter 1.3). In contrast to B-2 cells, B-1 cells are not thought to derive from 
CLP in the bone marrow in adult live but are generated from distinct precursors 
that can be found in fetal or neonatal live and in adult bone marrow. These 
precursors are defined as Lin-B220lo/-CD19+ cells (Düber et al., 2009; 
Montecino-Rodriguez et al., 2006). Although both populations are self-renewing, 
the activity for B-1a progenitors decreases after birth, while the activity for B-1b 
progenitors is active in neonatal and adult bone marrow (Düber et al., 2009; 
Martin and Kearney, 2001).  
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 Requirement of T cells 1.2.6
For their activation to differentiate into an antibody secreting plasma cell or a 
memory B cell, B-2 cells require direct contact with T cells, which takes place in 
the secondary lymphoid organs like spleen or lymph nodes. As naïve B cell, 
these cells express IgM and IgD. Depending on the cytokine-milieu that is 
available during the activation of a B cell, it is determined which kind of 
immunoglobulin it will express after differentiation. This process is called class 
switch as cells switch from expression of IgM/IgD to IgE, IgG or IgA (see 1.2.7, 
(Manis et al., 2002; Stavnezer et al., 2008)).  
On the other hand, it was shown that B cells are required for the development of 
T cell zones in spleen and the accumulation of DCs and T cells in this organ 
(Ngo et al., 2001). Furthermore, B cells can trigger the activation of T cells by 
presenting antigens via MHCII on their cell surface. In addition, B cells express 
CD80 and CD86 and thus can bind to the agonistic CD28 on T cells and hence 
promote T cell activation. However, it is not necessary that B cells activate T 
cells directly. Natural IgM or other Igs themselves can guide the polarization of T 
cell response by promoting the recognition of pathogens by professional antigen 
presenting cells (APCs), for example dendritic cells (Rapaka et al., 2010).  
As described shortly in this chapter, T cells and B cells have some influence on 
each other. Nevertheless, it is not clear yet, whether T cells are necessarily 
required for B cell development or only for their activation. 
 Class switch 1.2.7
During class switch, or isotype switch, the CH region of an antibody is changed. 
This is important for the effector function of the antibody as different subclasses 
bind with different affinities to special receptors on the surface of other immune 
cells or on epithelial cells. According to the strength of the binding, the activation 
of these cells can be triggered.  
Naïve B cells express IgM and IgD and in response to external signals, as 
cytokines released by T cells during activation of B cells class switch 
recombination (CSR) can be induced (Manis et al., 2002; Stavnezer et al., 
2008). CSR depends on DNA rearrangement and recombination between Sµ 
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(switch region, that lies directly upstream of genes encoding µ heavy-chain 
domains) and Sx region, located upstream of genes encoding the heavy-chain 
domains of isotype x (IgA, IgE, IgG1, IgG2a/b, IgG3) (see Figure 1.4.). For CSR, 
double stranded DNA breaks (DSBs) are required. This is promoted by the 
activation-induced cytidine deaminase (AID) as it deaminats dC to dU in the S 
regions and the subsequent repair of these dU residues leads to DNA breaks 
((Stavnezer et al., 2008) Figure 1.4). 
 
 
Figure 1.4 Diagram of Ig class switch recombination (CSR) from IgM to IgA 
(a) The mouse IgH locus in B cells expressing IgM and IgD (by alternative RNA 
transcription/processing). During CSR, activation-induced cytidine deaminase (AID) 
deaminates dC residues in the top and bottom strands of transcriptionally active S 
regions (Sµ and Sα in the diagram shown), initiating a process that results in double-
strand DNA breaks (DSBs) in both S regions and CSR by intrachromosomal deletion 
(b). (c) The IgH locus after CSR to IgA. Splicing diagrams of the µ, δ mRNAs and the 
germline α transcript are indicated below the diagram of the locus. Similar germline 
transcripts are induced from unrearranged Cγ,Cε, and Cα genes, depending on the 
cytokine stimulation received by the B cell (Stavnezer et al., 2008). 
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Nonhomologous end-joning of the DNA ends leads to excision of all DNA 
between the two switch regions and formation of a new immunoglobulin with the 
same variable region but a different CH. Thus, it results in a newly formed 
immunoglobulin. 
 IgM 1.3
Immunoglobulins are important for the humoral immune response in human and 
mice. B cells that secrete these molecules can be distinguished by their different 
expression of surface molecules (see chapter 1.2.5). In this chapter the nature 
of the IgM subset shall be described in more detail. 
Spontaneously secreted IgM can be found in all mice, even in naïve mice and 
those that are raised germ free or antigen free. This IgM is so called natural IgM 
(nIgM) and it is thought that it is produced by B-1a cells (Baumgarth et al., 2005; 
Kawahara et al., 2003; Thurnheer et al., 2003). Natural antibodies are important 
for the first line of defense against pathogenic bacteria (Zhou et al., 2007) as 
Streptococcus pneumonia (Haas et al., 2005) or pathogenic viruses (Baumgarth 
et al., 2000; Choi and Baumgarth, 2008) by guiding functional polarization of 
T cell responses. This is performed by promoting the recognition of pathogens 
by DCs or inducing class-switch recombination in activated B cells (see chapter 
1.2.7) and inducing long-term immune memory (Fernandez Gonzalez S, 2008; 
Rapaka et al., 2010). 
 Membrane bound or secretory IgM 1.3.1
Membrane-bound IgM (mIgM) differs from its secretory form (sIgM). mIgM is a 
monomeric molecule while sIgM can be found in serum in pentameric or 
hexameric form (Kaveri et al., 2012; Sitia et al., 1990). The different appearance 
of mIgM and sIgM is due to a difference in the heavy chain (µH). The constant 
region of µH consists of four domains (Cµ1-Cµ4). (Rogers et al., 1980). In 
addition, the membrane µH consists of a hydrophobic C terminal sequence of 41 
residues that can span the membrane. In contrast, the secretory µH consists of 4 
constant domains and a hydrophilic C terminal sequence of 20 residues, 
(Rogers et al., 1980). Switching from membrane µ to secretory µ is achieved by 
alternative splicing of the primary mRNA.  
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 Pentameric or hexameric IgM and the J chain 1.3.2
As mentioned before, secretory IgM can be detected as pentameric or 
hexameric form (Kaveri et al., 2012; Sitia et al., 1990). In serum, pentameric IgM 
is found in much higher concentrations than hexamers (Brewer et al., 1994; 
Shukala, 2009). Pentameric IgM consists of five IgM monomers and is generally 
associated with a joning (J)-chain. The monomers are covalently associated via 
disulfide bonds. The hexameric isoform consists of six monomers joined by 
disulfide bonds and does not contain the J-chain (Figure 1.5).  
The J-chain is a small protein that becomes exclusively incorporated into 
polymeric IgA (dimer) and pentameric IgM. It is about 15 kDa and is bound via 
disulfide bonds to the terminal cysteine of heavy chains (Randall et al., 1992).  
 
  
 
 
 
 
 
 
 
When comparing hexameric and pentameric IgM, the hexameric isoform is more 
efficient in activating the complement system compared to pentameric IgM 
(Brewer et al., 1994; Davis et al., 1988). It is thought that T cell-dependent 
Figure 1.5 Schematic representation of pentameric and hexameric IgM. 
Shown are the pentameric (left) and hexameric (right) isoforms of secreted IgM 
molecules. The pentameric IgM consists of five monomeric IgM molecules and is 
associated to a J-chain (red). The hexameric IgM consists of six monomeric IgM 
molecules without J-chain association. 
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immune responses lead to the stimulation of J-chain expression and therefore to 
a secretion of pentameric IgM, while T-independent immune responses might 
trigger the secretion of hexameric IgM (Brewer et al., 1994). The secretion of 
hexameric IgM might also be triggered preferentially when an enhanced 
complement activity is required, for example for elimination of invading 
pathogens. On the other hand, a higher activation of the complement cascade 
could lead to an overwhelming immune response if the secretion is not 
controlled. It is still not clear yet, which cells are secreting hexameric IgM. 
 Aim of the work  1.4
As described above, in mammals, B cell development starts already in the 
embryo thus a continuous production of B cells takes place. In the present work 
a mouse model was used in which B cell development can be switched on at 
any given time points such that the start of B cell development is synchronized. 
This mouse, called Indu-Rag1 contains an inverted and inverted floxed 
recombinantion-activating gene 1 (Rag1). Uninduced, it is lacking mature 
lymphocytes. These mice were crossed with MerCreMer mice, in which the Cre 
recombinase is fused to a mutated estradiol receptor and is under the control of 
the mb-1 promoter. In such mice (B-Indu-Rag1), Rag1 is not expressed but the 
expression can be induced in proB cells by oral administration of an estradiol 
analog, Tamoxifen (Düber et al., 2009). Using these transgenic mice, the 
developmental kinetics of B cell subsets and the usage of different VH genes 
early during ontogeny can be studied. Furthermore, it could be analysed 
whether B-1a cells that develop newly in BM are contributing to the B1 cell pool 
of an adult mouse. In addition, the question arose which cells are producing 
hexameric IgM that is found in serum of mice and humans (Figure 3.29, (Kaveri 
et al., 2012; Shukala, 2009; Sitia et al., 1990)). 
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2 Materials and methods 
 Mice 2.1
B-Indu-Rag1 mice (Düber et al., 2009), CB20 and Rag1-/- mice were kept under 
specific pathogen free conditions (SPF) and maintained in the animal facility of 
the Helmholtz Centre of Infection Research. BALB/c mice were bought from 
Janvier. Mice aged between 8-14 weeks were used for the experiments. For 
induction of B cell development or as control, 400 µl of a 20 mg/ml solution of 
Tamoxifen (Ratiopharm) in ClinOleic (Baxter) was administered orally.  
 Flow cytometry and cell sorting 2.2
Single cell suspensions: Cells were obtained by flushing lymphoid organs or the 
peritoneum of mice with ice-cold IMDM (Iscove’s modified Dulbecco’s medium, 
GibcoBRL/Invitrogen). Erythrocytes in splenic, or bone marrow preparations 
were lysed by incubation with ACK buffer (0.15 M NH4Cl, 10 mM KHCO3, 0.1 
mM Na2EDTA, pH 7.2) for 2-3 min on ice.  
Preparation of blood cells: For the isolation of cells originating from blood, 
cardiac-blood was collected into 500 µl of PBS including 50 µl 1:100 diluted 
heparin 25000 (ratiopharm). Erythrocytes were lysed by adding Erythrocyte-lysis 
buffer (2.06 g Tris-base, 7.49 g NH5Cl in a total volume of 1 l H2O, pH 7.2) for 5 
min at RT and afterwards centrifugation at 4 ˚C, 5 min at 1000 rpm was carried 
out. The supernatant was discarded and the steps were repeated until the cell 
pellet was white. 
Extracellular staining: Cells were stained for 10-15 minutes on ice using 
antibodies coupled to FITC, PE, APC, APC-Cy7, PE-Cy7 or Biotin from the list 
below (Table 1.1). Samples were washed twice with FACS buffer (PBS with 2 % 
FCS and 0.5 M EDTA) afterwards. Biotinylated antibodies were counterstained 
in a second step with streptavidin-FITC (eBioscience), streptavidin-PE 
(Southern Biotech) or streptavidin-PerCPCy5.5 conjugates (eBioscience) for 10 
min on ice, followed by a washing step with FACS buffer. 
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Table 2.1 Antibodies for FACS analysis 
Antigen Fluorescence Clone Company 
Mac-1 (CD11b) PE-Cy7 M1/70 eBioscience 
CD3 FITC 145-2C11 eBioscience 
CD5 
PE 
53-7.3 eBioscience 
APC 
CD4 APC RM4-5 eBioscience 
CD8 PE 53-6.7 eBioscience 
CD25 PE-Cy7 PC61.5 eBioscience 
B220 APC-Cy7 RA3-6B2 BDPharmingen 
IgD FITC 1.19 self made 
CD19 
APC-Cy7 
1D3 BDPharmingen 
APC 
CD43 Bio S7 BDPharmingen 
c-kit Bio ACK-4 self made 
CD21 Bio 7G6 BDPharmingen 
IgMa 
FITC 
DS-1 BDPharmingen 
PE 
IgMb PE AF6-78 BDBioscience 
CD40 PE 1C10 eBioscience 
IgA FITC polyclonal CaltayLaboratories 
CD23 PE-Cy7 B3B4 eBioscience 
AA4.1 (CD93) APC AA4.1 eBioscience 
 
Intracellular staining for BrdU: Stainings were done according to manufacturer’s 
protocol (FITC BrdU Flow Kit, BD Pharmingen). 
FlowCytomix for immune globulin measurement: The staining and analysis of 
the immune globulin concentrations in serum samples were performed 
according to manufacturer’s protocol (Mouse Immunoglobulin Isotyping Panel 
6plex FlowCytomix Multiplex, eBioscience). 
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Flow cytometry was carried out using analyzers LSRII or Fortessa (Becton 
Dickinson). Data were analyzed using DIVA software (Becton Dickinson) or 
FlowJo. Cell sorting was carried out on a FACSAria (Becton Dickinson). 
 Adoptive cell transfer 2.3
3*106 splenocytes, isolated from Igα-/- mice (10-14 weeks old) were injected i.v. 
in a volume of 100-200 µl sterile PBS into B-Indu-Rag1, wt or Rag-/- mice and 
were analysed by flow cytometry to confirm the composition (40-50 % of T 
cells). Alternatively, splenocytes from BALB/c mice were negatively sorted for T 
cells according to manufacturer’s protocol (Dynabeads® UntouchedTM Mouse T 
Cells, Invitrogen) and injected at the same numbers as T cells from Igα-/- mice 
(106 T cells per mouse transferred). 
 Bone marrow transfer 2.4
8-12 weeks old B-Indu-Rag1 mice were used as donors. Bone marrow cells of 
both femurs were prepared and 3*106 of these cells were injected i.v. into 
sublethally irradiated 8 weeks old Rag1-/- or CB20 mice. The recipients were 
induced 6 weeks after irradiation and analysed 3 weeks after. 
 ELISA 2.5
For collection of sera, blood was collected into Microvette 500 serum gel 
(Sarstedt, Germany). The tubes were kept at RT for 5 min and centrifuged for 5 
min at 10000 g. The supernatants were taken for serum analysis and stored 
at -20 °C. 
For collection of intestinal washout the small intestine was washed with 500 µl 
intestinal wash buffer (PBS including 0.1 mg/ml Trypsin-inhibitor, 50 mM EDTA, 
0.1 % BSA). The flow through was collected into 1.5 ml tubes and centrifuged 
10 min for 1000 rpm at RT. The supernatants were taken for intestinal washout 
samples and stored at -80 °C. 
For ELISA MaxiSorb plates (MaxiSorb TM Immunoplates, Nunc) were coated 
over night with 1 µg/ml anti IgM (clone II/41, BD Pharmingen), goat anti-mouse 
IgG (Sigma) or 5 µg/ml goat anti-mouse IgA (Sigma) antibodies diluted in 
coating buffer at 4 °C. After washing six times with ELISA wash buffer (PBS, 
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0.05 % Tween-20), wells were blocked with 200 µl blocking buffer (PBS, 0.05 % 
Tween-20, 3 % BSA) for one hour at RT. Afterwards plates were flicked to 
discard the fluid. The intestinal washouts or sera from different mice were 
diluted in blocking buffer and added to the plate for 2 h at RT. After washing six 
times, 0.5 µ/ml biotinylated anti IgM (clone LO-MM-9, AbDSeroTec), peroxidase 
coupled goat anti-mouse IgG (Jackson ImmunoResearch), or peroxidase 
coupled goat anti-mouse IgA (Sigma) antibodies in dilution buffer (1 % BSA in 
ELISA wash buffer) were added and incubated for 1 h at RT. Plates were 
washed and if biotinylated antibody was added the previous step horseradish 
peroxidase (HRP) conjugated streptavidin (BD Pharmingen) in dilution buffer 
was dispensed into the wells. Plates were incubated for 45 min at room 
temperature and washed. Then the ELISA was developed at RT for 5-20 min in 
the dark adding 1 mg/ml o-Phenylendiamin (OPD) in substrate solution and 
1:1000 diluted H2O2. The reaction was stopped adding 1 M H2SO4 and the 
results were read using an ELISA-reader (Dynatech, Germany) at a wavelength 
of 490 nm with reference wavelength of 340 nm. 
 ELISPOT 2.6
For ELISPOT MultiScreen IP plates (Millipore) were activated by adding 
10 µl/well EtOH and washed with PBS. Afterwards the plates were coated either 
with 100 µl/well anti-IgM (clone II/41, BD Pharmingen), anti IgA (clone C10-3, 
BD Pharmingen) or goat anti-mouse IgG (Sigma) in sterile PBS. Plates were 
incubated overnight at 4 °C. 
After washing once with blocking buffer (3 % BSA in PBS), wells were blocked 
with 100 µl blocking buffer for two hours at 37 °C. Afterwards plates were flicked 
to discard the fluid and washed with 200 µl PBS. The cell suspensions from 
different organs were serially diluted in IMDM medium and added to the plate for 
a overnight incubation at 37 °C 5 % CO2 and 95 % humidity. The next day, after 
washing plates five times with washing buffer (0.01 % Tween-20 in PBS), 0.5 
µ/ml biotinylated anti-IgM (clone LO-MM-9, AbDSerotec), biotinylated anti-IgA 
(clone 11-44-2, eBioscience) or biotinylated goat anti-mouse IgG (MABTECH) 
antibodies diluted in 0.01 % Tween-20 in blocking buffer were added and 
incubated for 30 min at room temperature. Plates were washed with 0.01 % 
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Tween-20 in blocking buffer and horseradish peroxidase (HRP) conjugated 
streptavidin (Pharmingen) in PBS was distributed into the wells. After washing 
and removing of Tween, plates were developed by adding 100 µl of substrate 
solution (333.3 µl of 10 mg AEC / ml DMF in 10 ml 0.1 M acetate solution with 5 
µl H2O2). Plates were kept in dark for a few minutes until spots were observed. 
Reaction was stopped by washing plates under running water and removing the 
plastic sheath underneath. Plates were left to dry overnight in the dark. Results 
were read using an ELIspot-reader (BD biosciences) 
 RNA isolation 2.7
RNA isolation was done from sorted cell subsets either by purification with an 
RNeasy MiniKit according to the manufacturer’s protocol, including DNase 
treatment on the column (RNeasy MiniKit, Qiagen) or isolated using peqGOLD 
TriFast according to the manufacturer’s protocol (peqGold TriFast, qeqlab). The 
RNA concentrations were measured with a NanoDrop Spectrophotometer 
(peqLab) and samples were either further processed or stored at -80 °C. 
 cDNA preparation (RT-PCR) 2.8
Depending on the protocol for RNA isolation the RNA was transcribed into 
cDNA. After isolation using the RNeasy MiniKit no DNase treatment was 
necessary. 2 µg of RNA (max. 12 µl) were mixed with 1 µl of oligo (dT)18 
(Fermentas) on ice and incubated at 65 °C for 5 min. Afterwards 8 µl of a 
mastermix (4 µl 5x reaction buffer, 1 µl RiboLock RNase Inhibitor, 2 µl 10 mM 
dNTPmix, 1 µl Reverse Transcriptase or DEPEC H2O as control, Fermentas) 
were added. The transcription was performed in a thermo cycler (5 min 25 °C, 
60 min 42 °C, 5 min 70 °C). Finally the samples were taken up in the required 
amount of DEPEC water. The DNA concentrations were measured with a 
NanoDrop Spectrophotometer (peqLab) and samples were either further 
processed or stored at -20 °C. 
If RNA was isolated using peqGold TriFast the DNA had to be digested first. 
This was done by adding 4 µl 5x Reaction buffer and 1 µl DNase (10 µg/µl 
Quiagen) to 2 µg RNA or a maximum of 15 µl of the RNA solution. The samples 
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were kept for 15 min at 37 °C following 10 min 60 °C incubation. Samples were 
then processed as described above. 
 PCR 2.9
 Primer 2.9.1
Table 2.2 Primer sequences for PCR and qPCR 
Gene Primer name Primer sequence 
Secretor. IgM 
forward 5’-TGTGTGTACTGTGACTCACAGGGA -3’ 
reverse 5’-AGGGAGACATTGTACAGTGTGGGT-3’ 
Membr. IgM 
forward 5’-TGTGTGTACTGTGACTCACAGGGA-3’ 
reverse 5’-TGTAGAAGAGGCTCAGGAGGAAGA-3’ 
J-chain 
forward 5’-CCTCTAGGATCATCCCTTCCACC-3’ 
reverse 5’-AATGGTATACAAAGTTCCTTCTC-3’ 
RPS9 
qPCRforRPS9 5’-TTGACGCTAGACGAGAAGGAT-3’ 
qPCRrevRPS9 5’-AATCCAGCTTCATCTTGCCCT-3’ 
PAX-5 
forward 5’-GCTACTCTGCACCGACGCTG-3’ 
reverse 5’-GGGCTGCAGGGCTGTAATAGT-3’ 
BLIMP-1 
forward 5’-AAGAGGTTATTGGCGTGGTAAG-3’ 
reverse 5’-ACTTCCTGTTGGCATTCTTGG-3’ 
CD138 
forward 5’-CCCCTCCTTTGACTTCTGCCT -3’ 
reverse 5’-GCAGTCGGGTCCCCTTTCT-3’ 
XBP-1 
forward 5’-TAGAAAATCAGCTTTTACGGGAGAAA-3’ 
reverse 5’-GGGCCTGCACCTGCTGCGGACTCAG-3’ 
IgM 
Cµ1 5’-ATGGCCACCAGATTCTTATCAGA-3’ 
VH cons. 5’-GAGGTGCAGCTGCAGGAGTCTGG-3’ 
 
 Gel electrophoresis 2.9.2
For separation of the cDNA an agarose gel electrophoresis was performed. 
Therefore 2 % agarose (Appligene, Germany) were solved in 1x TAE (50 x TAE: 
246 g Tris, 57.1 ml acetic acid, 100 ml 0.5 M EDTA, pH 8.0 in H2O with a total 
volume of 1 l) and after heating 0.01 % DNA stain G (1:200000 in TAE, Serva) 
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were added for staining of the DNA. Gels were run at 120 V for 40 min and DNA 
was visualised with UV light (Transilluminator TI 2: Biometra, Germany) and 
documented. To analyse the size of the DNA-fragments, a marker was used 
(O’GeneRuler 100bp RNA Ladder Plus, Fermentas). 
 Real-time PCR (qPCR) 2.10
For quantitative real-time PCR cDNA samples were used undiluted or diluted 
and mixed with 10 µl of primer-mix (see Table 2.2), 10 µl of sample and 20 µl of 
CYBR green (Applied Biosystems). As control, a mixture of all samples for each 
gene of interest was serially diluted for comparison possibilities of the samples. 
The PCRs were done in a 7500 Real time PCR system (Applied Biosystems). 
The program was as follows: 
50 ˚C 2’ 
95 ˚C 10’ 
 
40x 
95 ˚C 15” 
Temperature depending on primer 45” 
72 ˚C 2’ 
 
Dissociation step 
95 ˚C 15” 
60 ˚C 1’ 
95 ˚C 15” 
60 ˚C 15” 
 
Temperatures for primers: 
BLIMP-1 58 ˚C 
CD138 58 ˚C 
Secretory IgM 57 ˚C 
XBP-1 61 ˚C 
PAX-5 61 ˚C 
Membrane IgM 55 ˚C 
J-chain  55 ˚C 
RPS9 54 – 62 ˚C 
 
Samples were analysed with program 7500 (Applied Biosystems). 
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 Sequence analysis 2.11
 Preparation of cDNA 2.11.1
DNA was prepared as described above (see chapter 2.7, 2.8). Instead of 
oligo (dT)18, 0.5 µl Cµ1 and 0.5 µl VH cons (see Table 2.2) were used for 
amplification of IgH. 
 PCR 2.11.2
Afterwards a PCR was performed for amplification of IgH with specific primers 
added MIDs and Tags for identification of different samples after deep 
sequencing. Therefore primers of Table 2.3 were used. The reaction mix for the 
PCR were as follows (Thermo Scientific): 
2 µl TrueStart buffer 
2 µl NucMix 10mM 
1 µl VH cons deep primer 
1.6 µl 25 µM MgCl 
0.25 µl TrueStart HotTaq Polymerase (5 U/µl) 
11.15 µl DEPEC H2O 
  
18 µl of the reaction mix were provided into each tube and for each sample 1 µ 
of one of the Cµ2 deep primer and 1 µl of sample were added. PCR was 
performed according to following program on a thermo cycler peqStar (peqLab): 
95 ˚C 1’  
95 ˚C 30” 
35 x 55 ˚C 40” 
72 ˚C 40” 
72 ˚C 10” 
 
 
Table 2.3 Primer sequences for sequence analysis 
Primer name Primer sequence 
Cmu2_deep1 5’$CTATGCGCCTTGCCAGCCCGCTCAGAGTCCATTTGGGAAGGACTGA$3’!
Cmu2_deep2 5’$CTATGCGCCTTGCCAGCCCGCTCAGTAGGCATTTGGGAAGGACTGA$3’!
Cmu2_deep3 5’$CTATGCGCCTTGCCAGCCCGCTCAGGCATCATTTGGGAAGGACTGA$3’!
Cmu2_deep4 5’$CTATGCGCCTTGCCAGCCCGCTCAGCCGTCATTTGGGAAGGACTGA$3’!
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Cmu2_deep5 5’$CTATGCGCCTTGCCAGCCCGCTCAGAACTCATTTGGGAAGGACTGA$3’!
Cmu2_deep6 5’$CTATGCGCCTTGCCAGCCCGCTCAGGTACCATTTGGGAAGGACTGA$3’!
Cmu2_deep7 5’$CTATGCGCCTTGCCAGCCCGCTCAGCGTTCATTTGGGAAGGACTGA$3’!
Cmu2_deep8 5’$CTATGCGCCTTGCCAGCCCGCTCAGGGTACATTTGGGAAGGACTGA$3’!
Cmu2_deep9 5’$CTATGCGCCTTGCCAGCCCGCTCAGCACGCATTTGGGAAGGACTGA$3’!
Vhcons_deep 5’$CGTATCGCCTCCCTCGCGCCATCAGGAGGTGCAGCTGCAGGAGTCTGG$3’!
 
Gel electrophoresis was performed as described in chapter 2.9.2. 
 Purification of DNA from gels 2.11.3
For DNA purification from gels the MinElute Gel Extraction Kit (Qiagen) was 
used. Therefor the DNA bands of interest (approx. 400 bp) were cut out of the 
gel and the purification was done according to manufacture’s protocol. DNA 
concentration was then measured with a NanoDrop Spectrophotometer 
(peqLab). 
 Sequencing 2.11.4
After purification of DNA from gels and measuring DNA concentration samples 
were passed to Irene Grünke (MHH), who kindly performed the sequencing and 
first analysis of data. 
 IgM purification 2.12
For IgM purification different strategies were followed (chapter 2.12.1 and 2.12.2 
go together and chapter 2.12.3 to 2.12.5). 
 Radioactive labelling 2.12.1
Sort purified B cell subsets were incubated for 18 h with a mixture of DMEM 
without Cys or Met, 10 % IMDM, 3 % dialysed FCS, Pen/Strep (1:100) and 
300 µCi/ 100 µl 35S-Cys/Met (EasyTagTM EXPRESS35S Protein Labeling Mix, 
PerkinElmer). 
 Immunoprecipitation 2.12.2
Protein G immobilized agarose (Sigma) prepared according to manufacture’s 
protocol. The supernatants were incubated with anti-IgM (clone II/41, 
BDPharmingen) for 2 hours at 4 ˚C. After this incubation Protein G beads were 
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added (25 µl to 500 µl supernatant) and incubated for 2 hours at 4 ˚C. After 
washing the beads with PBS, the beads were resuspended in 20 µl Glycin-HCl 
buffer (pH 2.7). After 15 min, the supernatant was taken into a new tube and 
neutralized with 0.1 N NaOH. Afterwards a native PAGE was run (see chapter 
2.13). 
 Ammonium sulphate precipitation  2.12.3
Sera were mixed 1:1 with precipitation solution (1000 g/l ammonium sulphate in 
H2O, pH 7) over night at 4 ˚C. Afterwards the mixture was centrifuged 10 min at 
10000 rpm and the supernatant was discarded. The pellet was resuspended in 
PBS. Afterwards, the sample was dialysed at 4 ˚C over night in PBS and the 
samples were then used for IgM column (Econo-System) or stored at -20 ˚C. 
 Sepharose column for IgM purification 2.12.4
1 g of Sepharose (Sigma) was added into a 15 ml tube and washed four times 
with cold 1 mM HCl. In parallel 2 ml of coupling buffer (0.1 M NaHCO3, 
0.5 M NaCl, pH 8.3) were added together with 2 mg of anti-IgM (clon M41.42, 
selfmade) in a dialyse tube and dialysed against coupling buffer. Afterwards 
2 ml of the coupling buffer with M41.42 was added to the Sepharose and 
shaked overnight. The Sepharose was washed with 5 volumes of coupling 
buffer and blocked for two hours with 0.1 M Tris-HCl pH 8.0. The Sepharose 
was then washed repeatedly with 10 ml 50 mM Tris in 1 M NaCl pH 8.0 and 
10 ml 50 mM Glycine in 1 M NaCl pH 3.5. Sepharose was packed into a column 
and washed with 50 ml of PBS. Serum was run through the column very slowly, 
after washing with PBS elution was achieved with Glycine buffer. The samples 
were collected and dialysed over night at 4 ˚C against PBS. 
 Concentration of IgM 2.12.5
Samples were loaded into a dialysis tube, placed into a tray and covered with 
Polyethylene glycol 40000 (PEG). It was until the volume in the tube was 
reduced to the required volume and sample was transferred into a new tube. 
 Native gel 2.13
The samples (either radioactively labelled or concentrated) were put onto a 
native PAGE agarose gradient gel (Novartis). As control, each time a 
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NativeMark Unstained Protein Standard (Invitrogen) was added into one lane. 
This marker contained also pentameric and hexameric IgM. Thus, it was 
possible to simply visualize both isoforms. 
 Development of gels with purified IgM from serum 2.13.1
Incubating the gel in 0.1 % coomassie solution R250 in 5 % acetic acid and 
10 % Methanol and unstaining with H2O was used to visualize the proteins. 
 Development of gels with radioactive labelled proteins 2.13.2
Fixation of gels was performed according to manufacture’s protocol of the 
amplification reagent for increased detection efficiency (NAMP100, Amersham 
GE Healthcare). After keeping for 30 min in the amplification solution, gels were 
dried in a gel-drier (Biorad) for 30 min at 80 ˚C and exposed to an X-ray film 
(Amersham Hyperfilm MP, GE Healthcare) for several days. The film was then 
developed in a CURIX 60 (AGFA). 
 Statistical analysis 2.14
Statistical analysis was performed using Student t test with differences between 
means. Statistical p-values are given as * ≤ 0.05; ** ≤ 0.01; *** ≤ 0.001. 
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3 Results 
For the investigation of B cells development in adult mice the B-Indu-Rag1 
mouse was used. With this mouse model the kinetics of newly developing B cell 
subsets and the usage of different VH genes early during BCR recombination 
could be analysed. Furthermore the source of hexameric IgM should be 
discovered.  
 Inducible B cell development 3.1
The B-Indu-Rag1 mouse model was described before and proved that B cell 
development is inducible in such mice after Tamoxifen application. All B cell 
subsets could be found. In addition, it proved that BM derived progenitors in 
adult mice can develop into B-1a cells that populate the peritoneal cavity of such 
mice (Düber et al., 2009). These findings were obtained by several applications 
of the inducer before analysis of B cell subsets. Thus, synchronicity was lost to 
a large extend. Therefore, in the present work the induction was done only once 
to be able to analyse the differentiation steps of the newly developing B cells in 
a time dependent manner. 
In the publication of Düber and colleagues it was shown that in uninduced B-
Indu-Rag1 (InduRag mice on BALB/c background crossed to MerCreMer mice) 
mice an accumulation of B220+c-kit+ B cell progenitors could be detected similar 
to Rag1-/- mice (Düber et al., 2009). Upon induction of the B cell development 
these cells further developed and the percentage of the c-kit+ B cells declines 
(Düber et al., 2009). 
For answering the question how long it takes for a B cell pool to develop from 
B220+c-kit+ proB cells to a preB cell and to the subsequent populations, mice 
were induced once with Tamoxifen and analysed after five, six, seven, 11, 15 
and 21 days. Non-transgenic littermates (Rag1-/- mice) were used as control 
mice that do not develop B cells upon Tamoxifen administration and BALB/c 
mice were used as positive wild type (wt) control. 
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 Development of B cell progenitors in the bone marrow 3.1.1
In Rag1-/- mice an accumulation of B220+c-kit+ proB cells in the BM can be 
detected (Düber et al., 2009) while in wt mice these proB cell differentiate into 
preB cells. PreB cells can be divided into large preB I and preB II and small 
preB II cell subsets. They can be detected by flow cytometric analysis using 
appropriate surface markers. For unknown technical reasons, preB I cells could 
not be analysed because the c-kit staining did not reveal a distinct population. In 
the preB II population, large preB II cells express the surface markers 
B220+AA4.1+CD25+CD40-IgM-, while small preB II cells do express CD40 in 
addition (B220+AA4.1+CD25+CD40+IgM-).  
The gating strategy is shown in Figure 3.1. The percentages of precursor B cell 
populations were calculated and the differences over time are shown in Figure 
3.2. A clear increase of progenitor cell development from day 5 up to day 7 for 
the large preB II cells and from day 5 up to day 11 for the small preB II cells 
could be detected. On the days 7 and 11 the respective subset reached 
maximum (3-4 % or 0.5 % respectively). Since B cell development was only 
induced once, the percentages of the pre B II cell subsets decline after reaching 
the peak as no further proB cell differentiation replenishes the preB cell 
compartment. 
 
 
Figure 3.1 Flow cytometric gating for large (CD25+CD40-) and small (CD25+CD40+) 
preB cells. 
Shown is an example staining for BM cells of a B-Indu-Rag1 mouse analysed six days 
after induction. Cells were gated for lymphocytes first by checking forward and 
sideward scatter. Doublets were excluded by applying FSC area and heights against 
each other. Dead cells were excluded by gating for DAPI-negative cells. Those cells 
were then gated for B220+AA4.1+ cells for immature B cell population as shown. These 
cells were then gated for CD25 and CD40, IgM was excluded.  
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Figure 3.2 Development of B cell progenitors in bone marrow. 
After induction of B cell development mice were analysed at indicated time points. Blue 
line represents induced mice (Indu), while black lines with circle represent the 
percentages of indicated progenitor population in Rag1-/- mice (Rag) and black line with 
triangles indicates the populations from wt mice. Stars represent significance between 
Indu and Rag mice. 
 
3.1.1.1 Sequence analysis of early B cell progenitors 
The V region in the murine heavy chain contains 15 different families and more 
then 100 different gene segments (Chevillard et al., 2002; Chowdhury and Sen, 
2004). It was shown before that during fetal development of B cells the V gene 
segments proximal to the constant region are primarily used. Similarly, during 
early B cell development in adult BM such gene segments are found more often 
compared to their representation in the mature splenic B cell pool (Malynn et al., 
1990).  
Apparently, the pre-BCR plays an important role for the VH selection in B cells 
during adulthood, while it inhibits clonal expansion of preB cells in fetal liver 
(Wasserman et al., 1998). Depending on the location of the particular VH family, 
their activation for rearrangement is dependent on different signals e.g. gene 
segments, most distal of Cµ require IL-7 (Chowdhury and Sen, 2001). As 
consequence, a preferential usage of the proximal VH gene segments early and 
rearrangement of distal gene segments later during ontogeny was suggested. 
However, thus far this was never directly shown.  
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Figure 3.3 CDR3 length does not differ during early BCR rearrangement 
BM cells were isolated at indicated time points after induction and CDR3 length for IgM 
heavy chain was analysed by deep sequencing. As control large and small preB cells 
were isolated from BALB/c mouse. 
 
 
Thus, a time course of VH usage was established from day 1 after induction up 
to day 7, which coincided with the peak of large pre-B cells (Figure 3.2). In 
addition, large and small preB cells, isolated from BALB/c BM cells were 
included in the analysis. This experimental setup made it possible to analyse the 
very early gene-usages during B cell development without including cells that 
might have undergone several steps of rearrangement. First, this experiment 
revealed that the length of CDR3 at different time points remains the same 
(Figure 3.3). More importantly, as predicted, the VH usage varies over time 
(Figure 3.4). A clear shift from proximal to distal gene usage takes place. 
Although this result needs to be reproduced which was not possible for time 
constrains, it becomes clear that the postulated order of VH gene segment 
usage could be confirmed. 
 The occurrence of transitional B cells in different organs peaks at 3.1.2
day 11 post induction 
Immature B cells migrate out of the bone marrow via the blood stream into the 
spleen where they further mature. These B cells can be classified according to 
their surface markers into transitional 1 (T1) and transitional 2 (T2) B cells. Both 
subsets are CD19+AA4.1+. Upon their expression of CD23 and IgM it is possible  
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Figure 3.4 Proximal VH genes are used first during early IgM rearrangement. 
BM cells were isolated at indicated time points after induction and VH family usage was 
analysed by deep sequencing. As control large and small preB cells were isolated from 
BALB/c mouse. Usage of four proximal (IgHV3, IgHV14, IgHV2 and IgHV5) and one 
distal (IgHV1) V genes are shown. 
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to distinguish these two populations (Allman et al., 2001). The gating strategy is 
shown in Figure 3.5. 
 
 
Figure 3.5 Flow cytometric gating for T1 and T2 cells. 
Shown is a representative staining for cells isolated from BM of an induced Indu-B-
Rag1 mouse. Cells were gated for lymphocytes first by checking forward and sideward 
scatter. Doublets were excluded by applying FSC area and heights against each other. 
Dead cells were excluded by gating for DAPI-negative cells. Those cells were then 
gated for CD19+AA4.1+ as B cell progenitors and upon CD23 and IgM expression T1 
(CD23-IgM+) and T2 (CD23+IgM+) cells could be distinguished. Gating was performed 
for all analysed organs. 
 
In Figure 3.6 the increase and decline of T1 and T2 cells after a single induction 
of B cell development are shown. In all analysed organs the highest percentage 
of transitional B cells could be found at day 11 after induction. A significant 
increase could already be detected seven days after induction for the T1 subset 
but not for T2 cells. This demonstrates that the cellularity first increased in the 
T1 and then in the T2 compartment. This also confirms the notion of a stepwise 
maturation of transitional B cells (Allman et al., 2001; Allman and Pillai, 2008). 
Since the T2 cells differentiate from T1 cells the T2 population starts to increase 
later compared to T1. 
The sequential maturation also becomes very clear when the ration of the T1 
and T2 compartments is compared. In adult wt mice the ratio between the two 
different transitional B cell subsets remains equal over time since a continuous 
generation and maturation takes place. As B cell maturation in B-Indu-Rag1 first 
starts with the time of induction, the ratio has to change over time. In Figure 3.7  
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the data for BM and spleen are shown. Interestingly, T1 cells disappear after 15 
days, as the ratio declines nearly to zero in BM (Figure 3.7). At day 21 hardly 
any T1 or T2 cells could be detected in any organ of these mice. Thus, 
maturation is completed after this time period. 
 
 
Figure 3.6 Development of transitional B cells in BM, blood and spleen. 
After induction of B cell development, mice were analysed at indicated time points for 
the presence of T1 (left) and T2 (right) cells. The organs analysed were BM, blood and 
spleen (as indicated). Blue line represents induced mice, while black lines with circles 
represent the percentages of indicated transitional cells population in Rag1-/- mice, and 
black line with triangles indicate the populations isolated from wt mice. Stars represent 
significances between induced and Rag1-/- mice. 
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Figure 3.7 Ratio between T1 and T2 cells declines over time in induced mice. 
The ratio of T1 to T2 cells was calculated by the percentage of these two subsets in BM 
(left) and spleen (right). Stars indicate significances. 
 
 Proliferation of transitional B cells in induced mice is similar to 3.1.3
that of wt mice 
Similar low levels of proliferation of T1 and T2 cells without BCR stimulation had 
been detected before (Petro et al., 2002). This suggested an expansion of both 
populations.  
To study this idea in the B-Indu-Rag1 situation, the incorporation of BrdU by 
these cells was analysed. BrdU is an analogue of thymidine and can be 
incorporated into the newly synthesized DNA of replicating cells. Such cells can 
then be detected by using a BrdU-specific antibody. With the help of these 
antibodies the newly proliferating cells can be detected by flow cytometric 
analysis. 
To this end, mice were induced once with Tamoxifen. As the highest percentage 
of transitional B cells could be detected at day 11 after induction (Figure 3.6), 
cells were analysed at day nine since the cells should be proliferative at that 
time. Therefore, nine days after induction BrdU was given i.p.. After two hours 
cells from bone marrow, spleen and blood were analysed. In blood, no 
proliferating transitional B cells could be detected but in BM and spleen some 
(2 % and 0.1 %) proliferating T1 cells could be found (Figure 3.8). No 
proliferation of T2 cells could be observed. 
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Figure 3.8 Proliferation of T1 cells in BM and spleen. 
The proliferation of T1 in BM (left) and spleen (right) was analysed 9 days after 
induction. Therefore BrdU was given i.p. and two hours later the incorporation was 
analysed by flow cytometric analysis. 
 
 Mature B cell subsets in the spleen can be found from day 15 3.1.4
onwards 
Immature B cells migrate from BM to the spleen and mature (Chung et al., 
2003). To determine the time frame for this event, the first appearance of 
mature B cells was analysed. Mice were induced once and at different time 
points (day 5, 6, 7, 11, 15 and 21 after induction) appearance of the splenic B 
cell populations was established. All mature B cells are expressing CD19 and 
due to their differential expression of CD21, CD23 and CD5 they can be divided 
into the different subsets. An example of staining is shown in Figure 3.9. 
All B cell subsets can be found in significant numbers at day 15 after induction 
(Figure 3.10). While the percentages of B-1a cells and MZ cells approach the 
percentages of wt mice, the percentage of B-2 cells remains relatively low 
compared to wt mice. This might be due to the self-renewing capacity of B-1a 
and MZ B cells. In general, the percentages of B-1a cells and MZ cells (induced 
mice 0.3 % or 3 %) are much lower compared to that of the B-2 cell population 
(induced up to 10 %) (Figure 3.10). 
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Figure 3.9 Gating strategy for mature B cells in spleen. 
Shown is a representative staining for cells isolated from spleen of an induced B-Indu-
Rag1 mouse. Cells were gated for lymphocytes first by checking forward and sideward 
scatter. Doublets were excluded by applying FSC area and heights against each other. 
Dead cells were excluded by gating for DAPI-negative cells. Those cells were then 
gated for CD19 and furthermore classified according to the figure and CD23, CD21, 
CD5 expression. 
 
 First mature B cell subsets in the bone marrow are detectable at 3.1.5
day 15  
Not all mature B cells are residing in the spleen. Some migrate to other organs 
and some, after maturation in the spleen, migrate back to the bone marrow 
(Allman and Pillai, 2008). The time for the first mature B cells to develop and 
migrate back to the BM was analysed. For this, B cells were divided into two 
populations: Both expressing CD19, one population, mainly B-2 cells are 
IgM+IgD+ and another, consisting of B-1a cells, are IgMhiIgDlo (Figure 3.11). It is 
thought that especially IgM+IgD+ B cells in the BM is the main population that 
matures in the spleen and recirculates back to the BM (Loder et al., 1999). 
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Figure 3.10 Percentages of mature B cell subsets in the spleen increase over 
time. 
After induction of B cell development, splenocytes of mice were analysed at indicated 
time points for the presence of B-1a (upper left), MZ (upper right) and B-2 (low) cells. 
Blue line represents induced mice, while black lines with circles represent the 
percentages of indicated transitional cells population in Rag1-/- mice, and black line with 
triangles indicate the populations isolated from wt mice. Stars represent significances 
between induced and Rag1-/- mice. 
 
 
 
Figure 3.11 Gating strategy for mature B cells in BM 
Figure legend continues next page. 
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Shown is a representative staining for cells isolated from BM of an induced B-Indu-
Rag1 mouse. Cells were gated for lymphocytes first by checking forward and sideward 
scatter. Doublets were excluded by applying FSC area and heights against each other. 
Dead cells were excluded by gating for DAPI-negative cells. Immature B cells were 
excluded by gating for CD19+AA4.1- cells that could be further divided into IgMhiIgDlo 
and IgM+IgD+ cells. 
 
 
 
  
Figure 3.12 Increase of IgM+IgD+ cells in BM 15 days after induction 
After induction of B cell development, BM cells were analysed at indicated time points 
for the presence of IgM+IgD+ (left) and IgMhiIgDlo (right) B cells. Blue line represents the 
induced mice, while black lines with circles represent the percentages of indicated 
transitional cells population in Rag1-/- mice, and black line with triangles indicate the 
populations isolated from wt mice. Stars represent significances between induced and 
Rag1-/- mice. 
 
The results showed that the IgMhiIgDlo population of B1a cells does not increase 
significantly upon induction. However, 15 days post induction the first mature 
IgM+IgD+ cells can be detected in the BM (Figure 3.12). In general, like in wt 
mice, only very low percentages of IgMhiIgDlo B cells could be detected in the 
BM (max. 0.6 %, Figure 3.12), while the main mature B cell population in the BM 
consists of IgM+IgD+ B cells. In induced mice, the IgM+IgD+ population rises up 
to 0.6 %, whereas it is about 7 % in wt mice (Figure 3.12). 
 Mature B cell subsets in the peritoneal cavity are found from day 3.1.6
11 onwards and can still be detected after 8 weeks 
The peritoneal cavity is the site where B-1a cells mainly reside. These cells are 
the main producers of natural IgM. They can react to T cell-independent 
stimulation and act as innate-like cells (Alugupalli et al., 2004). Their task in the 
immune system is to quickly produce antibodies upon infection. In contrast to B-
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2 cells, B-1a cells are self-renewing and their progenitors are mainly found in 
fetal liver. Nevertheless, also in the adult BM some progenitors for B-1a cells 
are present. Therefore newly developing B-1a cells might be found in the 
periphery (Düber et al., 2009). Two other B cell populations commonly found in 
the peritoneal cavity are B-1b and B-2 cells. 
 
 
Figure 3.13 Gating strategy for peritoneal mature B cell populations 
Shown is a representative staining for cells isolated from peritoneal cavity of an induced 
B-Indu-Rag1 mouse. Cells were gated for lymphocytes first by checking forward and 
sideward scatter. Doublets were excluded by applying FSC area and heights against 
each other. Dead cells were excluded by gating for DAPI-negative cells. Cells were 
further subdivided upon their expression of CD19, CD43, Mac-1 and CD5. 
 
In Figure 3.13 an example of staining for the B cell subsets in peritoneal cavity 
is shown. While both B-1 cell subsets express CD19, CD43 and Mac-1, only 
B-1a cells are also expressing CD5 on their cell surface. B-2 cells on the other 
hand are expressing only CD19 and are negative for the other markers. 
It could be shown that in the peritoneal cavity first B-2 cells can be detected 11 
days after induction, whereas the B-1 cell subsets are found from day 15 
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onwards (Figure 3.14). While the percentages of B-1a and B-2 cells are not 
reaching the level of wt mice, the percentage of B-1b cells in the peritoneal 
cavity is rising above wt-level (17 % compared to 6 % after eight weeks, Figure 
3.14). Also the absolute number of B-1b cells in induced mice is reaching that of 
wt mice eight weeks after induction. In contrast, the absolute numbers of the 
other subsets do not reach wt-level (data not shown). 
 No significant differences in B cell proliferation between induced 3.1.7
and wt mice 
To analyse whether the increase of the B cell subsets in B-Indu-Rag1 mice is 
due to proliferation of these cells during development or whether they 
exclusively differentiate from progenitors, the proliferation of CD19+ B cells was 
analysed by injecting BrdU 15 days post induction. This time point was chosen 
as the highest numbers of the different subsets could be detected at day 21 
after induction and day 15 was the first day all subsets could be seen in 
significant numbers (Figure 3.10, Figure 3.14). It could be shown, that there was 
no significant proliferation comparing CD19+ cells isolated from spleen or 
peritoneal cavity from induced mice compared to wt mice (Figure 3.15). 
Therefore the question remains where the higher percentages, especially of 
B-1b cell population over time arise from, as no progenitors can be detected 
after day 11 and the transitional B cell subsets also vanish at day 21 (Figure 
3.15). 
 Immunoglobulin concentrations increase over time in serum and 3.1.8
gut 
To analyse the functionality of the induced B cell populations, it is necessary to 
investigate their ability to produce immunoglobulins and whether this is 
comparable to wt mice. Therefore, the concentration of immunoglobulins in 
serum of the different mouse groups was analysed using Mouse 
Immunoglobulin Isotyping Kit. 
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Figure 3.14 Mature B cell subsets in peritoneal cavity rise from day 11 or 15 
onwards 
After induction of B cell development, peritoneal cavity cells of mice were analysed at 
indicated time points for the presence of B-1a (upper left), B-1b (upper right) and B-2 
(low) cells. Blue line represents induced mice, while black lines with circles represent 
the percentages of indicated transitional cells population in Rag1-/- mice, and black line 
with triangles indicate the populations isolated from wt mice. Stars represent 
significances between induced and Rag1-/- mice. 
 
 
 
Figure 3.15 No significant differences in B cell proliferation between induced and 
wt mice. 
The proliferation of CD19+ B cells isolated from spleen (left) or peritoneal cavity (right) 
was analysed 15 days after induction. Therefore BrdU was given i.p. and two hours 
later the incorporation was analysed by flow cytometric analysis. 
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With this experiment it was possible to show, that comparable to the increase of 
the B cell subsets in the different organs the first immunoglobulins could be 
detected at day 15 after induction (Figure 3.16). Nevertheless, this is true only 
for IgM, IgG2a and IgG3. The other immunoglobulin subsets can be detected 
first in significant amounts after 21 days of induction (IgA and igG2b), while 
IgG1 was not increasing significantly at all. At the same time, the highest 
concentration could be detected for IgM with a tendency of reaching wt levels. 
This is the only immunoglobulin that rises to a concentration of 50 µg/ml. All 
other immunglobulins do not rise above 1 µg/ml (Figure 3.16). Switching of B 
cells to one of the other immunoglobulins is obviously not supported since it 
might require T cell help. 
 
 
Figure 3.16 Immunoglobulin concentrations increase in serum of induced mice. 
Figure legend continues next page. 
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The indicated immunoglobulin concentrations in serum of the indicated mouse groups 
were measured using Mouse Immunoglobulin Isotyping Kit. Days after induction are 
indicated. Blue line represents induced mice, while black lines with circles represent the 
percentages of indicated transitional cells population in Rag1-/- mice, and black line with 
triangles indicate the populations isolated from wt mice. Stars represent significances 
between induced and Rag1-/- mice. 
 
In addition to their residence in the peritoneal cavity, B-1 cells are able to 
migrate to intestinal lamina propria (Allman and Pillai, 2008). For some time, it 
was believed that they are key players in the intestinal immune response by 
switching to IgA secreting cells in a T cell independent manner (Allman and 
Pillai, 2008). However, recently it was shown that IgA+ cells, isolated from 
intestine might not derive from B-1a, but rather from B-1b cells (Roy et al., 
2013). To analyse the functionality in the induced mice and to investigate the 
time IgA requires to accumulate in the gut, intestinal washout was analysed by 
ELISA for IgA at 11, 15 and 21 days after induction. 
In the induced mice, nearly no increase of IgA concentration in the intestinal 
wash out was detectable (Figure 3.17). The concentration does not increase 
further than 230 ng/ml at day 21 after induction, compared to 500 µg/ml in wt 
mice. 
 
 
  
Figure 3.17 IgA concentration in intestinal wash out is not significantly increased 
after induction 
IgA concentrations of the intestinal washout of different mouse groups (Rag1-/-, induced 
mice and wt control) were measured by ELISA at indicated time points after induction. 
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Figure 3.18 Amount of IgM secreting cells increases in spleen over time 
Number of IgM secreting cells were measured by ELISPOT in BM and spleen at the 
indicated time points after induction from Rag1-/-, induced and wt mice. 
 
 Increase of IgM secreting cells over time 3.1.9
To confirm the IgM concentration in serum of the induced mice is due to the 
increase of B cells that are secreting IgM and not due to a few B cells that 
secrete high amounts IgM over time, ELISPOTs for the different time points for 
spleen and BM were performed. The results are shown in Figure 3.18. The 
number of IgM secreting cells is increasing over time in the spleen. While there 
are only 15 IgM secreting cells/ 105 cells detectable in spleen 11 days after 
induction, this number increases to 125 IgM secreting cells/ 105 cells at day 21 
after induction. In the BM only at day 11 very low numbers of IgM secreting cells 
could be detected in the induced mice suggesting that such IgM secreting cells 
are short lived plasma cells.  
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 T cell requirement for B cell development 3.2
It is known that for the induction of B cell responses, especially B-2 cell 
activation, T cell help is required. Recently it was reported, that in humanized 
mice, T cells are also required for the maturation of human B cells as such cells 
would rest in the transitional stage without T cells (Lang et al., 2013). To 
analyse whether there is some influence of T cells on B cell maturation in mice, 
T cells were adoptively transferred one day before induction of B cell 
development. As it could be shown here that B cells can mature without T cells, 
the question whether increased B cells development would become apparent 
and whether there might be a difference in B cell composition. Thus, the mice 
were analysed 21 days after induction. At this time point all subsets were 
present as pointed out above. In addition, mice were analysed after eight 
weeks, to reveal whether there is a difference in long-term maintenance. 
 No differences when injecting T cells isolated from wt spleen or 3.2.1
injection of splenocytes isolated from Igα-/- mice 
For analysing the requirement of T cells for B cell development, splenocytes of 
Igα-/- mice (that do not have B cells) were injected intravenously into B-Indu-
Rag1 mice.  
As T cells from Igα-/- mice might harm B cell development (Roy, unpublished 
data), differences in B cell development using whole splenocytes from Igα-/- 
mice and negatively isolated T cells from BALB/c splenocytes should be tested. 
With the help of flow cytometric analysis the percentage of T cells in 
splenocytes of Igα-/- mice was calculated and the same number of T cells 
isolated from BALB/c splenocytes were injected into mice to ensure comparable 
numbers (Figure 3.19). One day after adoptive transfer of T cells, B cell 
development was induced and mice were analysed 21 days after induction. As 
shown in Figure 3.20, no differences between the B cell subsets in spleen or 
peritoneal cavity could be observed. Therefore splenocytes from Igα-/- mice did 
not harm the B cell development and could furthermore be used as T cell 
donors for the experiments. 
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Figure 3.19 Transfer T cells from BALB/c or Igα-/- mice have same containing 
percentages of CD4+ and CD8+ T cells 
Transfer T cells from BALB/c mice (upper panel) or Igα-/- mice (lower panel) were 
analysed for the appearance of CD4 or CD8 upon CD3+ T cells. Doublets were 
excluded by applying FSC area and heights against each other. Dead cells were 
excluded by gating for DAPI-negative cells. Number in quadrants in far right dot plots 
indicate percentages of subsequent T cell subsets from all T cells. 
 
 Number of mature B cells in spleen after induction and T cell 3.2.2
administration is higher than without T cells 
The results for spleen as the primary organ of maturation are shown first. In 
Figure 3.21 the different mouse groups are shown 3 and 8 weeks after 
induction. The B cell subsets could be divided into B-1a, MZ and B-2 cells (see 
chapter 3.1.4). For B-1a cells it could be shown, that this population is found in 
significantly higher numbers when T cells are available (Indu+T) than without T 
cells (Indu). For MZ and B-2 cells this is true for the later (8 weeks) or earlier (3 
weeks) time point respectively (Figure 3.21). 
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Figure 3.20 No significant differences when using T cells isolated from Igα-/- mice 
or BALB/c mice 
Shown are total cell numbers for indicated B cell subsets in peritoneal cavity (left) and 
spleen (right). Control groups are Rag1-/- (Rag), and wt mice. For comparison induced 
mice that got T cells from BALB/c mice (Indu + T B/c) and induced mice that got T cells 
from Igα-/- mice (Indu + T Iga-/-) are shown. 
 
 Number of mature B cells in BM and peritoneal cavity after 3.2.3
induction and T cell administration 
For analysis of the B cell subsets in the periphery and of those cells that migrate 
back to the BM, the peritoneal cavity and the BM were analysed 3 and 8 weeks 
after induction. In the BM the mature B cells were divided into IgM+IgD+ and 
IgMhiIgDlo B cells (see chapter 3.1.5). In the peritoneal cavity the different B cell 
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subsets B-1a, B-1b and B-2 could be distinguished by surface staining shown 
before (see chapter 3.1.6). 
 
 
Figure 3.21 Increased number of B cells in spleen if T cells are available. 
Indicated B cell subsets from different mouse groups are shown as indicated for 3 or 8 
weeks after induction. Significances were calculated and marked by stars between 
induced mice (Indu) and induced mice additionally adoptive transferred T cells 
(Indu + T). Control groups are Rag1-/- (Rag) and wt mice. 
 
In both organs nearly no significant difference in cell numbers could be 
observed whether T cells are available for their differentiation or not (Figure 
3.22, Figure 3.23). In the BM nearly no mature B cells could be detected after 
induction, while in the peritoneal cavity cell numbers are increasing over time. 
Only in the B-2 cell subset a significant difference between Indu and Indu+T 
mice could be found three weeks after induction (Figure 3.23). At this time point 
more B-2 cell can be detected in those mice that had adoptively transferred T 
cells available. Five weeks later (8 weeks after induction) this significant 
difference could not be seen anymore (Figure 3.23). The cell numbers of all B  
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Figure 3.22 No significant difference between B cell subsets in BM whether T 
cells are available or not. 
Indicated B cell subsets in different mouse groups are shown as indicated for 3 or 8 
weeks after induction. Significances were calculated and marked by stars between 
induced mice (Indu) and induced mice additionally adoptive transferred T cells 
(Indu + T). Control groups are Rag1-/- (Rag) and wt mice. 
 
 
Figure 3.23 Only significant differences in B-2 cell population in peritoneal cavity 
whether T cells are available or not. 
Figure legend continues next page. 
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Indicated B cell subsets in different mouse groups are shown as indicated for 3 or 8 
weeks after induction. Significances were calculated and marked by stars between 
induced mice (Indu) and induced mice additionally adoptive transferred T cells 
(Indu + T). Control groups are Rag1-/- (Rag) and wt mice. 
 
cell subsets, except B-1b cells in the peritoneal cavity, did not reach the cell 
numbers of those that could be seen for wt mice. The B-1b cell subset reached 
the level of wt mice 8 weeks after induction. This is in consensus with the higher 
percentage of B-1b cells after induction although no T cells were available (see 
chapter 3.1.6). There were no significant differences detectable with or without T 
cells available (Figure 3.23). 
 Immunoglobulin concentrations increase upon availability of T 3.2.4
cells in serum and intestinal wash out 
As T cells obviously influence the development of B cell maturation in some 
way, the effect on the immunoglobulin secretion was analysed. Therefor serum 
from mice was taken at different time points after induction and was analysed 
using Mouse Immunoglobulin Isotyping Kit. The results are shown in Figure 
3.24. 
No differencees in IgM concentrations between induced (Indu) and induced 
mice that have T cells available (Indu+T) could be observed. In contrast, for all 
other immunoglobulins (IgA, IgG1, IgG2a, IgG2b and IgG3) differences were 
found. For each immunoglobulin the concentration is significantly higher at day 
21 post induction when T cells are available. Analysing later time points, no 
significant differences could be observed any more, except for IgA, there the 
significant higher concentration in mice that have seen T cells are also visible at 
8 weeks post induction (Figure 3.24). 
Similarly, in intestinal wash out the IgA concentration was altered. Mice that 
received adoptively transferred T cells show higher IgA concentrations 
compared to induced mice without T cell transfer after three and after eight 
weeks of induction (Figure 3.25). 
 
Results  55 
 
 
 
Figure 3.24 Immunoglobulin concentrations are slightly higher in induced mice if 
T cells are available. 
The indicated immunoglobulin concentrations in serum of the indicated mouse groups 
were measured using Mouse Immunoglobulin Isotyping Kit. Days/weeks after induction 
are indicated. Blue line represents induced mice, red line represents induced mice that 
got T cell transferred, while black line with circles represent the serum concentration of 
indicated immunoglobulin in Rag1-/- mice, and black line with triangles indicate that of 
wt mice. Stars represent significances between induced  and induced mice that 
recieved T cells (Indu+T). 
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Figure 3.25 Higher IgA concentration in intestinal washout if T cells are available. 
IgA concentrations of the intestinal washout of different mouse groups (Rag1-/-, 
induced, induced+T mice and wt control) were measured by ELISA at three weeks (left) 
and eight weeks (right) after induction. 
 
 
 More immunoglobulin secreting cells when T cells are available 3.2.5
It is known that for the switching of naïve B cells to IgA, IgG and IgE T cells are 
required (Manis et al., 2002; Stavnezer et al., 2008). As the concentrations of 
immunoglobulins are much higher in those mice that had adoptively transferred 
T cells available (see chapter 3.2.4) the question arose whether this is due to a 
few B cells that secrete high numbers of immunoglobulins, or whether this is 
due to the fact that much more cells have switched from IgM to IgA or IgG -
secreting cells. To analyse this, ELISPOTs for IgM, IgG and IgA were performed 
at day 11, 15 and 21 after induction for cells isolated from BM and spleen. 
It could be shown that the IgM secreting cell number increases, whether T cells 
are available or not and this is independent of the availability of T cells (Figure 
3.26). For IgG and IgA significant differences could be observed. The number of 
IgG or IgA secreting cells isolated from splenocytes is higher if T cells are 
available (Figure 3.26). 
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Figure 3.26 Higher number of IgG and IgA secreting cells if T cells are available. 
Number of immunoglobulin secreting cells per 105 cells for cells isolated from spleens 
out of the indicated mouse groups are shown. Immunoglobulins are indicated. Time 
after induction for IgM are day 11, 15 and 21 (as indicated), for IgG day 11 and for IgA 
day 21 are shown. Stars indicate significances between induced mouse groups with 
(Indu+T) and without (Indu) T cell administration. 
 
 Functionality of newly developed B-1a cells 3.3
As it is still in debate whether B-1a cells can arise from adult bone marrow the 
B-Indu-Rag1 mouse was created. Here and before (Düber et al., 2009) it could 
be shown that there are detectable numbers of B-1a cells arising from mice that 
only have B cell development in adulthood. It was shown, that those B-1a cells 
are functional, as they spontaneously secrete IgM, show PtC specificity and can 
survive in Rag1-/- mice after adoptive transfer (Düber et al., 2009). In the present 
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work it should be analysed, whether these newly developing B-1a cells can 
compete with those in an established B cell environment. Thereby the aim was 
to analyse whether it is likely, that B-1a cells are developing from their 
progenitors also in adulthood if a complete immunoenvironment is present. 
 B-1a cells developing from adult bone marrow can contribute to 3.3.1
the adult B-1a cell pool 
To analyse the potency of the adult BM to give rise to B-1a cells when a 
functional B cell environment is already present, BM chimeric mice were 
established. For this Rag1-/- or CB20 mice, that express a different IgM allele on 
their B cells (IgMb) and can therefore be distinguished from B cells arising from 
B-Indu-Rag1 mice (IgMa), were sublethally irradiated. Subsequently these mice 
were reconstituted with BM cells isolated from B-Indu-Rag1 mice. Mice were 
kept for six weeks to establish a functional BM environment and then mice were 
induced once. 21 days after induction these mice were analysed for their B cell 
subsets that were derived from the BM of the donor mice by flow cytometry. The 
main B cell populations in the peritoneal cavity are arising from IgMb 
progenitors, i.e. cells of the recipient strain (Figure 3.27).  
 
 
Figure 3.27 Newly developed B cells can be found if need to compete with 
already developed B cells are found in environment. 
Shown is the flow cytometric analysis of peritoneal cavity of a CB20 mouse sublethally 
irradiated and complemented with BM from B-Indu-Rag1 mice after induction of the 
B cell development. Doublets were excluded by applying FSC area and heights against 
each other. Dead cells were excluded by gating for DAPI-negative cells. Cells from 
recipient and donor mice could be distinguished upon their expression of different IgM 
allotypes (IgMa donor B cells; IgMb recipient B cells). 
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Figure 3.28 B cell development after induction is dependend on the presence of 
complete immunoenvironment. 
CB20 or Rag1-/- mice were sublethally irradiated and complemented with BM from B-
Indu-Rag1 mice. After induction of B cell development the appearance of newly 
developed IgMa+ B cells was analysed. Shown are the percentages of B cell subsets 
from all newly developed IgMa+ (donor) B cells in peritoneal cavity. 
 
But, with this experimental setup, it could also be shown that in the peritoneal 
cavity the donor BM cells (IgMa) give rise to newly developed B cell populations 
(Figure 3.27). Nearly all newly developed B cells in the peritoneal cavity can be 
designated as B-2 cells (77 %) indicating that the percentage of B-2 cells from 
all newly developed IgMa+ B cells is higher when there is a complete 
immunoenvironment existing already. Nevertheless, B-1a cells could be found in 
the peritoneal cavity of those mice. Nevertheless, the percentage of B-1a cells is 
lower when B cell development is induced in CB20 (27 % to 6 %; Figure 3.28). 
In the spleen, also nearly all B cells arose from donor progenitors (IgMb+) (data 
not shown). Thus, precursors in the adult BM are able to contribute to the adult 
pool of B1a cells. 
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 Pentameric or hexameric IgM 3.4
Natural IgM are mainly produced by B-1a cells (Baumgarth et al., 2005; 
Kawahara et al., 2003; Thurnheer et al., 2003). These immunoglobulins are also 
found in uninfected individuals and mice that are pathogen or even antigen free. 
It is generally accepted, that B cells are able to secrete pentameric and 
hexameric IgM. It could be shown, that both isotypes can be found in serum of 
mice and human (chapter 3.4.1 (Kaveri et al., 2012; Sitia et al., 1990)). Until 
now, it is not clear which B cell subset produces the hexameric IgM and what is 
the benefit secreting this isoform. Pentameric IgM consists of five monomeric 
IgM molecules and contains a joining (J-) chain, while hexameric IgM does not 
contain a J-chain (Brewer et al., 1994; Davis et al., 1988). In this part of the 
present work the aim is to figure out, which B cell subset is secreting hexameric 
IgM. 
 Normal serum contains pentameric and hexameric IgM 3.4.1
In the present work the appearance of hexameric and pentameric IgM in serum 
of different mouse strains could be confirmed by isolating IgM by an IgM-specific 
column from these different sera. After eluting the serum-IgM from the column, it 
was concentrated and a gradient native PAGE was performed to separate 
pentameric and hexameric IgM due to their size. The used marker contained 
purified IgM in both isoforms and was always added in one lane as control. The 
gel was stained with Coomassie to make the proteins visible. One 
representative gel is shown in Figure 3.29. It can be seen, that in each serum of 
the different mouse strains, both, pentameric and hexameric IgM could be 
detected. This confirms the data of previous findings (Shukala, 2009). 
 
 
Figure 3.29 Serum of different mouse strains contains hexameric and pentameric 
IgM. 
IgM was isolated from sera of indicated mouse strains and a native PAGE was 
performed for separating pentameric and hexameric IgM according to their size.  
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 More J-chain expression compared to secretory IgM in splenic B-3.4.2
1a cells but not in peritoneal B-1a cells  
It is commonly known that B-1 cells isolated from peritoneal cavity can secrete 
IgM without stimulation (Holodick et al., 2010; Kawahara et al., 2003; Thurnheer 
et al., 2003). Nevertheless, the spot size is very small and it was discussed 
whether these spots may be due to cell lysis or shedding. Recently it was shown 
by Holodick and colleagues that such spots arise from real secretion from B-1 
cells (Holodick et al., 2010). Thus the question arose, which differences may 
exist between B-1 cells and the other B cell subsets with regard to IgM 
secretion. For answering the question whether the smaller spot size might be 
due to different secreted forms of IgM, the J-chain expression of the different B 
cell subsets and in the same analysis also the IgM expression were analysed. 
This was done by isolating the different B cell subsets from peritoneal cavity and 
spleen according to the gating shown in Figure 3.30.  
 
  
Figure 3.30 Sort for splenic and peritoneal B cell subsets. 
The sorting for splenic (left) and peritoneal cavity (PeC, right) B cell populations that are 
negative for IgA are shown. 
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The relative expression of different genes from these subsets was analysed by 
real-time PCR. It could be shown before, and in the present work it could be 
confirmed, that J-chain is mainly expressed by splenic B-1a cells (Shukala, 
2009) Figure 3.31). But, at the same time also the level of expression of 
secretory IgM is much higher in these cells compared to other B cell subsets 
(Figure 3.31). In the present work, the ratio of expressed secretory IgM 
compared to expressed J-chain was calculated as this could give a hint of the 
usage of J-chain for the assembling of IgM. The level of J-chain expression 
compared to IgM is much higher in peritoneal cavity compared to that of IgM in 
splenic B cells (Table 3.1). This led to the suggestion that these cells might give 
rise to hexameric IgM. 
 
 
 
Figure 3.31 IgM and J-chain expression differ between different B cell subsets. 
qPCR results for relative expression compared to RPS9 of membrane bound 
(membr.) -, secretory (secr.) IgM and J-chain are shown. B cell populations and the site 
of isolation (P=peritoneal cavity; S=spleen) are indicated. 
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Table 3.1 Ratio of IgM/J-chain is lower in splenic B cells compared to peritoneal 
B cells 
Organ B cell subset Ratio IgM/J-chain expression 
 
Peritoneal cavity 
B-1a 4.8  
B-1b 2.3  
B-2 4.2  
spleen 
B-1a 0.6  
MZ 0.8  
B-2 0.6  
 
 
   
 Transcription factors differ between different B cell subsets 3.4.3
For further analysis of differences between the different B cell subsets that could 
give a hint for different secretion pattern, the expression of transcription factors 
and plasma cell marker were analysed. It was suggested that there is a cascade 
of transcription factors that is found in Ig secreting cells. This cascade includes 
four different transcription factors: B cell leukemia/lymphoma-6 (BCL-6), B 
lymphocyte inducer of maturation program 1 (BLIMP-1), paired box gene 5 
(PAX-5) and X-box binding protein 1 (XBP-1) ((Tumang et al., 2005) and 
reviewed in (Calame et al., 2003; Lin et al., 2003)). Tumang and colleagues 
analysed the expression of these transcription factors in peritoneal B-1a cells, 
unstimulated and stimulated splenic B-2 cells. The analysis aimed to show 
phenotypic similarities between B-1a cells and plasma cells (Tumang et al., 
2005).  
To analyse whether there are differences in the expression of the different 
transcription factors between all B cell subsets, and to investigate whether one 
of the unstimulated B cell subsets shows a more plasma cell like expression 
pattern, the subsets were sorted according to the gating in Figure 3.30 and 
analysed for their relative expression of three of the transcription factors (Figure 
3.32). It could be shown that the expression differs only for PAX-5, that is 
expressed at higher levels in B-2 and MZ cells. In addition the expression of 
CD138, a plasma cell marker was analysed. In Figure 3.32 it is shown that it 
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was highest expressed in splenic B-2 cell subset and lowest for peritoneal B-1a, 
B-1b and MZ B cells. 
 
 
Figure 3.32 Only different expression of PAX5 and CD138 between different B cell 
subsets. 
Shown are the relative expressions compared to RPS9 for the indicated transcription 
factors (BLIMP-1, PAX-5, XBP-1) or plasma cell marker (CD138). B cell populations 
and the site of isolation (P=peritoneal cavity; S=spleen) are indicated. 
 
 Splenic B cell subsets are not likely to secrete hexameric IgM 3.4.4
As the analysis of transcription factors did not reveal clear significant differences 
between the B cell subsets, another experiment was performed to establish 
which B cell subset is secreting hexameric IgM. To this end, different B cell 
subsets from peritoneal cavity and spleen were sorted, cultured and the 
supernatants were analysed for secreted IgM. The concentrations of the 
secreted IgM were expected to be very low in the supernatants of such cultures. 
LPS stimulation to gain higher concentrations could not be carried out as this 
induces J-chain expression (Shukala, 2009). Therefroe, radioactive labelled 
amino acids were added to the medium and IgM was isolated by 
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immunoprecipitation. The isolated IgM was separated according to their size by 
a gradient native PAGE. As control, marker with pentameric and hexameric 
isoform of IgM was added into one lane. Unfortunately most cells died after one 
day of culture already. Therefore, it was impossible to keep cells for longer than 
18 hours. Nevertheless, the amount of secreted IgM still remained low. Thus, it 
was not possible to unambiguously detect IgM in the supernatant of peritoneal 
B-1 cell populations. A very faint band was detected for hexameric IgM for 
peritoneal B-1a cells. Nevertheless it was possible to show that neither splenic 
B-1a cells nor splenic B-2 cells are secreting hexameric IgM (Figure 3.33).  
 
 
Figure 3.33 Splenic B-1a and B-2 cells secrete pentameric IgM 
Different cell populations were sorted and incubated for 18 hours with radioactive 
labelled amino acids. IgM from supernatants was isolated by immunoprecipitation and a 
native PAGE was performed for distinguishing hexameric and pentameric IgM by size. 
Arrows indicate size of molecules at this position given by a marker containing 
pentameric (1048 kDa) and hexameric (1236 kDa) IgM. S=spleen P=peritoneal cavity. 
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4 Discussion 
The newly established Indu-Rag1 mouse is a highly versatile system to study 
lymphocyte development. Depending on the Cre recombinase that is crossed 
into this mouse strain different questions can be answered. For instance, the 
Indu-Rag1 mouse was crossed to a Rosa26-creERT2 mouse, in which the Cre 
recombinase is fused to a mutated estradiol receptor and is under the control of 
the Rosa26 promoter that is ubiquitously active. The induction of the Cre in 
these mice leads to the continuous development of B and T cells because Rag 
is activated in hematopoietic stem cells. In recent publications this mouse was 
used to show that γδT17 cells were not generated after genetic restoration of 
defective Rag1 function in adult mice (Haas et al., 2012) and that FoxP3+ T cells 
are commited to a stable lineage that is present already during early stages of 
murine thymic Treg development (Toker et al., 2013). When the Indu-Rag1 
mouse is crossed with MerCreMer mice, in which the Cre recombinase is fused 
to a mutated estradiol receptor and is under the control of the mb-1 promoter 
Rag1 will be only expressed in proB cells. This leads to a single wave of 
maturation because such pro-B cells are not replenished like the stem cells. 
With this mouse (B-Indu-Rag1) an old puzzle could be unambiguously resolved 
namely whether adult bone marrow progenitors are able to produce functional 
B-1a cells (Düber et al., 2009). Additional phenomena that are claimed to occur 
during B cell development could be proved in the present work. 
All results on B cell development in B-Indu-Rag1 mice were gained by several 
rounds of induction (Düber et al., 2009). Now in the present work, B cell 
development was induced as a single wave. This single wave made it possible 
to analyse the minimal time newly developing B cells need for their maturation 
and for the population of different organs. It turned out that proB cells 
differentiate into preB cell subsets within five days. The maximum of these two 
subsets can be detected in the BM seven or 11 days after induction, 
respectively. The clear order of differentiation could be observed. First the large 
preB cells develop and later on the small preB cells, as the latter population 
peaks later as the first one. Small preB cells are known to differentiate from the 
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proliferating large preB cell population. Interestingly, although the order of 
differentiation is from large preB II to small preB II such cellular compartments 
appear at the same time. How can this be reconciled? In the large preB II cell 
heavy chain rearrangement takes place while in the small preB II cells the light 
chain is assembled. Large preB II cells that quickly and functionally rearrange 
their heavy chain should also quickly reach the small preB II state. This would 
predict that such small preB II cells use mainly the proximal VH gene segments. 
This hypothesis can be tested by isolating such cells and establishing the VH 
usage.  
 
Table 4.1 Kinetics of B cell development 
Shown are the first significant appearances and, when existing the peak of appearance 
of the indicated B cell subsets isolated from indicated organs. BM=bone marrow; 
Bl=blood; S=spleen; P=peritoneal cavity. 
B cell subset 
Detected first 
[days] 
Peak of 
appearance [days] 
large preB II 5 7 
small preB II 5 7-11 
BM T1 6 11 
Bl   T1 7 11 
S    T1 7 11 
BM T2 7 11 
Bl   T2 7 11 
S    T2 11 11 
S    B-1a 15  
S    MZ 15  
S    B-2 11  
BM IgM+IgD+ 15  
P    B-1a 15  
P    B-1b 15  
P    B-2 11  
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Contrary to the clear order observed for preB cell development, such a clear 
order cannot be detected for transitional B cells. Both B cell subsets (T1 and T2) 
peak at day 11 post induction. Apparently, the synchrony that is still observed 
for preB cell development is lost now. However, in contrast to the T1 subset, the 
T2 subset remains detectable up to day 15 in blood and spleen. The fact that T1 
cells disappear first is consistent with the notion of stepwise maturation of 
transitional B cells and a precursor product relationship between T1 and T2 cells 
(Allman et al., 2001; Allman and Pillai, 2008). None of the progenitor subsets 
can be detected beyond 21 days after induction. Clearly only one wave of 
development takes place and by that time all progenitors have differentiated into 
mature B cells or have undergone apoptosis as this might also happen due to 
selection mechanisms.  
The first immature IgM+ B cells (T1 cells) can be detected 6-7 days post 
induction. This is consistent with data obtained for B cell development in fetal 
liver. Here, the first c-kit+ progenitors can be detected at day 11 after fertilization 
(de Andres et al., 2002). Six days later the first IgM+ B cells can be detected in 
the fetus (Raff et al., 1976). This is very similar to what was observed for the BM 
in the present work, where c-kit+ cells can be found still at day 0 of induction and 
the first IgM+ immature B cells appear 6 days later.  
Whereas, after a particular time progenitor and transitional B cells decrease in 
percentage, the mature B cell populations increase starting with day 11. This 
indicates that B-2 cells need a minimum of 11 days for full maturation. Again 
one would predict that such cells are using the proximal VH gene segements as 
they have been maturing extremely quickly.  
Interestingly, B-1 and MZ B cells appear later than B-2 cells. This could indicate 
that the differentiation of such B cells requires more time. However, there is no 
indication for such scenario. More likely is that the precursor frequency for such 
cells is lower than for B-2 cells. Therefore, it requires more time for these cells 
to accumulate in significant numbers. Eight weeks after induction, B-1a and 
B-1b cells can still be found in elevated percentages in peritoneal cavity. In 
contrast, B-2 cells are lost to some degree. This is coinsistent with the notion 
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that B-1 cells are self-renewing while the majority of B-2 cells needs to be 
replenished from precursor cells.   
The higher percentage of B-1b cells in induced mice compared to wt mice is 
consistent with data shown before (Düber et al., 2009). None of the other B cell 
populations in the peritoneal cavity increases that much. The reason for the 
differential increase of the B-1b population is still unclear. A possible 
explanation could be that the recently described precursor for B1 cells in BM 
leads mainly to B-1b cells (Montecino-Rodriguez et al., 2006). 
In the spleen, 15 or 21 days after induction MZ and B-1a cells are found in 
similar percentages compared to the populations in wt mice. Since B-1 cells are 
known to be self-renewing (Forster and Rajewsky, 1987; Hayakawa et al., 1986) 
one would expect that these cells are proliferating to gain their normal level in 
the different organs. However, no significant increase in proliferating cells was 
detectable in the induced mice compared to wt mice. One might argue that the 
BrdU labelling did not work. However, other cell subsets were positive for BrdU 
(data not shown). Thus, the increase of the population cannot be explained by 
self-renewal. The expansion of such cells must therefore take place at a level 
that is not accessible for the analysis carried out here. Most likely the early 
precursor already proliferate in such a way that the increased numbers can be 
explained.   
The first detection of serum immunoglobulin is on day 15 after induction. By that 
time also B-1 and MZ B cells can be detected while B-2 cells are found already 
before. This is consistent with the idea that B-1a cells are the main contributors 
of secreted IgM. By ELISPOT assays the first IgM secreting cells could be 
detected by day 11. Apparently this does not lead to a significant increase in 
secretory IgM. It needs to be shown whether these IgM producing cells are of 
B-1a or B-2 origin. Both B cells should lead to short lived plasma cells under 
these conditions (Shapiro-Shelef and Calame, 2005) since no IgM secreting 
cells could be found in BM at that time points.  
Interestingly, other Ig subclasses can also be found in serum by day 21. The 
production of such Igs is believed to require T cell help. However, the 
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concentration of such serum antibodies is extremely low. Thus, it can be 
explained by the leakiness of the immune system that allows also the switch to 
subclasses other than IgM at a low efficiency.  
Despite of the presence of IgG and IgA in serum, no Ig could be detected in the 
intestinal wash out. This was surprising since the GALT (gut associated 
lymphoid tissue) is known for mechansims that support a T-independent CSR 
(Barone et al., 2009; Macpherson et al., 2000). Obviously, IgA secreting cells 
had not colonized yet the lamina propria of the gut.   
To analyse whether T cells have an input on the development of B cells in 
adulthood, splenocytes isolated from Igα-/- mice containing T cells were injected 
intravenously one day before induction of B cell development. This should give 
rise to an environment with T cells that would then be encountered by the newly 
developed B cells. In a recent publication it was shown that T cells are required 
in humanized mice for the development of B cells, as they would otherwise rest 
in the transitional stage (Lang et al., 2013). In the present work it could be 
shown, this is not the case for mouse B cells. No block at the transitional stage 
can be observed.  
Interestingly, for splenic B-1a cells a T cell effect could be observed. The 
numbers are significantly increased in mice that received adoptively transferred 
T cells compared to those that were induced without T cells. In contrast, 
peritoneal B-1a cells appear to be completely independent on T cells. No 
increase in the cell number could be observed. The reason for this T cell effect 
in the spleen is unclear. It is known that B-1a cells react to their specific antigen 
in a T-independent manner (Yang et al., 2012). In addition, the differences 
between B-1a cell populations from spleen and peritoneal cavity are still ill 
defined. Possibly, migration of B1a cells to the spleen is supported by T cells. 
This has been observed in our group before (Roy et al., to be published).  
T cells also have an impact on MZ and B-2 cells in the spleen. The findings 
might indicate that T cells are important especially for the early differentiation or 
maintenance of B-2 cells. They are found in higher numbers after three weeks 
of induction. At later time points this difference is no longer seen. Therefore T 
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cells might support a faster development of B-2 cells in the spleen, as this 
increase in number is also found in peritoneal cavity.  
The impact of T cells on MZ B cells appears to act mainly on maintenance 
because their numbers are increased at 8 weeks quite in contrast to B2 cells. 
 To investigate how much the function of B cells after induction is influenced by 
the presence of T cells, the production of immunoglobulins was analysed. It is 
known that the cytokine milieu that is at least in part dependent on T cells, acts 
on the type of CSR during activation of B cells (Manis et al., 2002; Stavnezer et 
al., 2008). Thus, the appearance of some of the immunoglobulin subsets is 
highly dependent on the presence of T cells (Lentz and Manser, 2000). 
Therefore, the immunoglobulin concentrations in the serum of induced mice that 
received adoptively transferred T cells were compared to sera of induced mice 
without T cell. After 21 days (at this time point the first significant amounts of 
immunoglobulins could be detected in only induced mice) also the concentration 
in the serum of those mice that have T cells available was higher compared to 
those without T cells. This was consistent with the finding that there are more 
immunoglobulin secreting B cells in mice that received T cells. Even for 
intestinal wash out it could be shown that the IgA secretion is highly dependent 
on such T cells (Barone et al., 2009). Obviously still a high number of B cells do 
require T cells for the switching to IgA-secreting cells and possibly also for 
migration.  
The higher serum concentration of immunoglobulins in mice that received 
T cells is lost at later time points, except for IgA that remains higher. Obviously 
T cells are required for activation and switching of the B cells that newly develop 
but only short lived plasma cells develop under these conditions except for IgA. 
This might be due to the continuous stimulation of the immune system by 
commensal bacteria that are located in the gut of SPF mice. These stimuli are 
supposed to activate B cells in a T cell-independent manner (Macpherson et al., 
2000), but obviously this is not sufficient for an increase in IgA concentration, 
neither in intestinal washout, nor in serum. 
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T cells definitively help B cells in maturating to immunoglobulin secreting cells. 
This could be confirmed by ELISPOT. The number of immunoglobulin secreting 
cells is increasing for IgG and IgA, when T cells are available. For IgM no 
increase could be shown. This might demonstrate the T cell independence of 
IgM secreting cells  
It was for long time in debate whether adult BM can give rise to B-1a cells or 
whether this is an exclusive property of fetal progenitors. Here and before 
(Düber et al., 2009) it could be shown that also from adult BM B-1a cells can 
develop. By analysing their ability to bind PtC and spontaneously secretion of 
IgM it could be shown that these B-1a cells are functional (Düber et al., 2009). 
As these B-1a cells are developing in an immunodeficient environment it could 
be still argued that the adult BM might not give rise to these B-1a cells when a 
complete and functional immunoenvironment is present. In addition, it was not 
formally shown that B-1a cells derived from adult BM are contributing to the 
adult B-1a cell pool. Therefore a BM chimera was established in which B cell 
development could be induced in a “normal” environment. B-1a cells could 
derive from these newly induced B cell progenitors. In addition, it could be 
shown that the progenitors more likely develop into B-2 subset than into B-1 
subsets when other B cells are available. Why this might happen and what 
regulates progenitors to become B-2 cells rather than B-1a cells when a 
complete immunoenvironment is available has to be answered. Obviously the B-
1 cell niche is saturated already in these immuncompetent mice and the number 
of B-1 cells does not rise above a certain level. Possibly, as soon as the B-1 cell 
niche in the periphery is filled a feedback to the BM takes place and no more 
cells will differentiate into B-1 cells. The still high differentiation into B-2 cells 
might be due to the fact that B-2 cells are short lived compared to B-1 cells and 
therefore need more replacement and renewal. The fact, that in some transfer 
experiments, no newly developed B-1a cells could be found (Kantor and 
Herzenberg, 1993) might be due to the fact that the percentage of newly 
developed B-1a cells is very low and it might be taken that no new development 
of these cells takes place. It was shown before that B-1 cells are newly 
developing from adult bone marrow (Düber et al., 2009; Holodick et al., 2009), 
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but in these cases the newly developed cells did not have to compete with a 
functional immunoenvironment. In the present work it could be clearly shown 
that also in immunocompetent mice B-1a cells do develop from adult BM-
progenitors and contribute to the adult B-1a cell pool to some extend. 
It is known that in serum IgM can be detected in pentameric and hexameric 
isoform (Kaveri et al., 2012; Sitia et al., 1990), whereas pentameric IgM is found 
in much higher concentrations (Brewer et al., 1994; Shukala, 2009). To 
investigate whether a specific B cell subset is secreting hexameric IgM, the 
relative expression of secretory IgM and J-chain was compared. It could be 
shown that the ratio of IgM to J-chain is much higher in peritoneal B cell subsets 
compared to the splenic B cell subsets. Thus, the peritoneal B cells might 
secrete hexameric IgM as this isoform does not contain J-chain. And as the 
highest expression of IgM compared to J-chain was found in peritoneal B-1a 
cells these cells were thought to be most likely cells that are secreting this 
isoform. By analysing the supernatants from sort-purified B cell subsets it could 
be excluded that splenic B-1a and splenic B-2 cells are the cell subsets that are 
secreting hexameric IgM. Due to very low IgM secretion of peritoneal B cells, 
the analysis of these subsets did not yield conclusive results. The native PAGE 
analysis revealed a minor band for hexameric IgM for supernatants from B-1a 
cells. Nevertheless, ambiguity remains for technical reasons. 
To investigate further differences between the different cell subsets, it was 
analysed whether the expression of transcription factors that are acting in a 
cascade in Ig secreting cells (Tumang et al., 2005) might differ between the 
different cell types. This should give a hint on differences between the different 
cell subsets. The only differences could be observed in PAX-5 expression. This 
transcription factor is normally found in elevated levels when B-2 cells are non-
secreting (Tumang et al., 2005). Thus, B-1 cells display a more secretory 
phenotype. Unfortunately the expression patterns for the other transcription 
factors do not fit to that finding. XBP-1 and BLIMP-1 did not differ between these 
subsets. In addition CD138, a marker for plasma cells, was elevated in splenic 
B-2 cells. Therefore, the analysis of the relative expression of neither of the 
transcription factors, nor of CD138 answers whether B-1a cells are the hexamer 
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secreting cell subset or not. Therefore in the present work it could be shown that 
peritoneal B-1a cells secrete pentameric as well as hexameric IgM. 
Unfortunately the evidence is not completely compelling. 
Previous studies showed that in young adult bone marrow cells the proximal VH 
genes are used more often (Malynn et al., 1990). This could be confirmed by 
using the B-Indu-Rag1 mouse. In the first days of B cell development the 
proximal genes, close to DJ are used and at later days the distal (J558) genes 
were used in higher frequency. As the J558 gene family is a large family it could 
be argued that simply more genes are used over time. On the other hand the 
clear shift from proximal to distal gene usage can be seen as there are by day 
seven post induction around 40 % of gene segments used from the J558 family, 
whereas it is only 10 % by day 1-3. Apparenty, an individual B cell precursor has 
the chance to rearrange a proximal VH gene segment first. As the process is 
slow, only some cells will be able to successfully assemble a VH gene. These 
cells most likely finish maturation with minimal times. Cells that require more 
time for rearrangement have then the complete repertoire available, since the 
locus is now completely open due to cytokine activity or other not yet defined 
signals.  
As in normal wt mice, the B cell development is not synchronized this could not 
be clearly found in earlier experiments. It was also shown before that isolated B 
cell precursors that were isolated from Rag2-/- mice the histone assembly and 
therefore the active recombination with these genes was highly dependent on 
IL-7 for the distal genes (Chowdhury and Sen, 2001). In the present mouse 
model, it would be possible to investigate this in vivo. IL-7 given systemically at 
the time of induction should result in activation of distal genes to be used for 
assembling VH genes in the first days of B cell development.  
The present work adds new aspects that are addressed by using the B-Indu-
Rag1 mouse. Thus, this mouse model offers a highly versatile tool to investigate 
early steps of B cell development in vivo as the first differentiation steps are 
synchronized. Similarly, aspects of T cell development can be investigated 
using appropriate combination of inducible Cre.  
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5 Summary 
For the present work the B-Indu-Rag1 mouse has been used to investigate the 
kinetics of B cell development in adult mice. In this mouse, Rag1 which is 
required for T and B cell development is inverted and flanked by inverted loxP 
sites. When crossed with a mouse that bears a Cre that is fused with a mutated 
estradiol receptor under the control of the B cell-specific mb1 promoter, 
expression can be induced by administration of Tamoxifen. This leads to one 
wave of B cell development.  
Uninduced mice contain a pool of c-kit+ proB cells. Such cells can differentiate 
upon Tamoxifen induction. Thus, the time that B cells and their precursors need 
for maturation can be determined. ProB cells need five days to differentiate into 
preB cells and it takes another two days to detect the first transitional B cells in 
different organs. This is in agreement with the development observed in fetal 
liver. The progenitor and the immature B cells peak at a certain time point which 
is consistent with the notion that the induction under these circumstance leads 
to a single wave of B cell development.  
Using the synchrony at the early time points after induction, it was possible to 
demonstrate that during heavy chain recombination in progenitor B cells the VH 
genes proximal to the DJ segments are used first and the distal VH segments 
are rearranged later during B cell ontogeny.  
Analysis of the mature B cell populations revealed an earlier appearance of B-2 
cells compared to B-1 and MZ B cells. This could be simply due to the precursor 
frequency for such B cells which might be higher for B-2 cells. Importantly, no 
proliferation could be found neither for transitional nor for mature B cells. 
Apparently, expansion takes place only at the precursor level. 
Using BM chimera it could be shown that B-1a cells developing from adult 
progenitors contribute to some extend to the B-1a cell pool in adult mice. 
In addition the source of hexameric IgM was analysed. Peritoneal B-1a cells 
appear to secrete pentameric and hexameric IgM, while splenic B cells clearly 
do only secrete pentameric IgM.  
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The present work adds compelling data for the development and function of 
B cells in adult mice. Furthermore it shows that the B-Indu-Rag1 mouse model 
is a highly versatile tool to investigate questions regarding development of 
B cells in particular and lymphocytes in general. 
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6 Appendix  
 Abbreviations 6.1
 
Ab antibody 
AID activation-induced cytidine deaminase 
APC Allo-Phyco-Cyanin 
BCR B cell receptor 
Bio Biotin 
BM bone marrow 
bp base pairs 
C constant region gene segment 
CD Cluster of differentiation 
cDNA complementary DNA 
CDR complementary-determining region 
CLP common lymphoid progenitor 
CSR class switch recombination 
Cys cysteine 
D diversity gene segment 
DAPI 4′,6-Diamidin-2-phenylindol 
DMF dimethyl-floramid 
DNA deoxyribonucleic acid 
DSB double stranded DNA breaks 
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EDTA ethylene-diamine-tetra-acetate 
ELISA enzyme-linked immunosorbent assay 
ELISPOT enzyme-linked immuno spot assay 
et al. et alii 
FACS fluorescence-activated cell sorter 
FCS fetal calf serum 
FITC fluorescein isothiocyanate 
FO follicular 
FSC forward scatter 
H heavy 
HRP horseradish peroxidase 
HSC hematopoietic stem cell 
i.e. id est 
Ig immunoglobulin 
IL interleukin 
IMDM Iscove’s modified Dulbecco’s medium 
J joining gene segment 
J joning 
L light 
Mb mega bases 
Met methionine 
MHC major histocompatibility complex 
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mIg membrane Ig 
mRNA messenger RNA 
MZ marginal zone 
PBS phosphate buffered sline 
PCR polymerase chain reaction 
PE phycoerythrin 
PHSC pluripotent hematopoietic stem cell 
pre precursor 
pro progenitor 
Rag recombination activating gene 
RNA ribonucleic acid 
RT reverse transcription 
RT room temperature 
sIg surface immunoglobulin 
SL surrogate light (chain) 
SPF specific pathogen free 
T transitional 
TdT terminal deoxynucleotidyl transferase 
wt wild type 
! !
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